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The aim of this study was to assess the acute and post-acute services for ischaemic 
stroke patients in the Cape Metro Health District in relation to the South African 
ischaemic stroke guideline. 
 
Part A: Protocol 
 
The protocol outlines the purpose of the study and highlights the importance of 
conducting this study by analysing the literature on stroke care in both high and low and 
middle income countries. The literature also highlights the gaps in stroke care in South 
Africa which justify the need for this study. The protocol also outlines the methods of 
data collection and analysis as well as the ethical considerations. 
Part B: Literature Review 
 
This expands on the literature on the different components of both acute and post-acute 
stroke care in both high and low and middle income countries. It also elaborates on 
stroke in South Africa and why it is important to conduct this study. 
Part C: South African Medical Journal manuscript 
 
The manuscript summarises the whole study and includes the literature on stroke 
care, justification of the study and how the data was collected and analysed. The 
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1.1 Purpose of the study 
1.2 Aims 
To assess the acute and post-acute services for ischaemic stroke patients in the Cape 
Metro Health District in relation to the South African ischaemic stroke guideline over the 
period 2016 to 2017. 
1.3 Objectives 
i. To describe the acute and post-acute ischaemic stroke services offered to
ischaemic stroke patients in level 1, 2 and 3 hospitals in the Cape Metro Health
District
ii. To compare the acute and post-acute ischaemic stroke services offered to
patients with ischaemic stroke against the South African ischaemic stroke
guidelines
iii. To identify any barriers to optimum patient care encountered by the health
facilities in providing the acute and post-acute ischaemic stroke care services
2.0 Background 
Strokes are an important global cause of disability and premature death in adults (Brainin 
et al., 2007, Mohd Nordin et al., 2014). In 2010, globally, strokes were responsible for 
approximately 5.9 million deaths, 33 million prevalent cases and 102.2 million 
Disability Adjusted Life Years (DALYs) lost, of which 71%, 52% and 78%, 
respectively, were from Low and Middle Income Countries (LMIC) (Feigin et al., 2014). 
Unlike in the high income countries where strokes affect particularly the elderly, in 
LMIC, a substantial proportion of the economically active younger populations are 
affected and this has significant adverse effects on the health the populations as well as 
the economies of these countries (Strong et al., 2007). Therefore, strokes in LMIC are an 
important health as well as economic concern. 
Strokes in South Africa are also a significant public health problem. According to 
Statistics South Africa, in 2013, cerebrovascular diseases were ranked fourth in the top 
ten leading causes of death in South Africa after Tuberculosis, the respiratory infections; 
Influenza and pneumonia, and Human Immunodeficiency Virus (HIV). Cerebrovascular 
diseases accounted for approximately 4.9% of deaths in South Africa (Statistics South 
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Africa, 2015). 
Strokes can be broadly classified into two categories; haemorrhagic and ischaemic. 
The difference between the two categories is in their mechanism of action. A 
haemorrhagic stroke results from the rupture of a weakened blood vessel which causes 
bleeding into and around the brain. An ischaemic stroke occurs as a result of a clot or 
embolus obstructing blood flow in the brain. Ischaemic strokes are the most common and 
comprise approximately 87% of cases (Summers et al., 2009). This study in the Cape 
Metro Health District will focus on some components of the medical management and 
care of the more common ischaemic strokes. 
In the acute phase of care, an important objective in managing an ischaemic stroke 
involves maintaining homeostasis through active management of the physiologic 
abnormalities such as dehydration, hypoxia, hypoglycaemia and abnormal blood 
pressures. Other important objectives include the prevention of complications as well as 
implementing strategies to re- establish perfusion of the brain (Bryer et al., 2010). This 
latter objective can be accomplished with the use of drugs such as tissue plasminogen 
activator that break down the clot or emboli. In some cases, endovascular procedures that 
physically break down the clot can be performed. These interventions have been found to 
have significant positive effects on patient outcomes when delivered in a stroke unit 
model of care by a dedicated multidisciplinary team (MDT) (Dennis and Langhorne., 
1994). 
A stroke unit is a geographically defined area in the ward or hospital where stroke 
patients are managed by a MDT (de Villiers et al., 2009). The MDT of healthcare 
professionals includes doctors, nurses, physiotherapists, occupational and speech 
therapists, dieticians, social workers and psychologists (Bryer et al., 2010). Ongoing 
training of this team is essential so that they remain coordinated and organized. Apart 
from the MDT, another unique feature of the stroke unit concept is the education of 
the patient and their caregivers on strokes; this includes information about the 
complications that may arise, secondary prevention and care that should be given at 
home. The early involvement of the patient and their caregivers in the treatment and 
rehabilitation process helps with the continuation of care when the patient is discharged 
home. 
Stroke patients managed in stroke units have been found to have better outcomes compared 
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to those not managed in stroke units (Indredavik et al., 1991, Kalra et al., 2005, 
Langhorne et al., 1993, Stroke Unit Trialists’ Collaboration, 1997, Sun et al., 2013). In 
one of the earlier trials conducted between 1986 and 1987 at a local university hospital 
in a town in Norway, 220 stroke patients were randomly allocated into those managed 
in a stroke unit and those managed in general medical wards (Indredavik et al., 1991). 
The participants in this study included a mix of ischaemic and haemorrhagic strokes; 
however, the distribution of the different diagnoses was similar in the 2 groups. 
Outcomes in the study measured at 6 and 52 weeks were to determine mortality, the 
functional state of the participants and the proportion of participants living at home and 
those living in an institution. 
The log-rank test was used to compare the 2 groups; stroke unit and general medical ward. 
In the intention to treat analysis at 6 weeks, the proportion of participants who had died or 
were living in an institution was lower in those managed in the stroke unit compared 
to those managed in the general medical ward (p values of 0.027 and 0.02, respectively). 
At 6 weeks, the proportion of those who had died was 7.3% for the stroke unit compared 
to 17.3% for the general medical ward and the proportion of those living in an institution 
was 36.3% for the stroke unit and 50% for the general medical ward. The proportion of 
those living at home was 56.4% for those managed in the stroke unit and 32.7% for 
those managed in the general medical ward, and this was also statistically significant (p 
= 0.0004). The results at 52 weeks were similar to those found at 6 weeks. Those 
participants managed in the stroke unit had a statistically significant persistently higher 
functional state (mean neurological score) compared to those managed in the general 
medical ward when measured at both 6 and 52 weeks (p values 0.007 and 0.004 
respectively). 
In summary, the study found that patients managed in a stroke unit are more likely to be 
alive and living at home as well as have a higher functional state which allowed them 
to be less dependent on caregivers when compared to patients managed in the general 
medical wards. However, the absence of blinding was an important weakness noted in this 
study which could have introduced observer bias and influenced the results of the study. 
Similar results were obtained in a single blinded randomized control trial conducted 
more than a decade later in England by Kalra et al in 2005. In this study, stroke patients 
managed by an MDT in a stroke unit were compared to those receiving home based care 
by a specialist home based team and those managed in general medical wards with 
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support from a stroke team. Participants were recruited from the stroke register and 
from the 979 on the register, 457 were randomised into the three groups; acute stroke 
unit, general medical ward and home based care. 
The main outcomes of the trial were institutionalisation or death at 1 year. The trial 
found that there were fewer deaths and cases of institutionalisation at 1 year in those 
patients managed in the acute stroke unit (13.5%) compared to those managed in the 
general medical wards (30.2%) and also compared to those who received home based care 
(23.6%). At 1 year, those managed in the stroke unit were found to have a 54% reduced 
relative risk of dying or being institutionalised compared to those who were managed 
by the stroke team in the general medical wards (RR 0.46 [95% CI 0.3-0.72], p =0.001). 
The study also found that at 1 year, those managed in the stroke unit had a 41% 
reduced relative risk of dying or being institutionalised compared to those managed by 
the specialist home based team (RR 0.59 [95% CI 0.37-0.95], p = 0.03) (Kalra et al., 
2005). In this study, stroke patients managed in a stroke unit were found to have better 
outcomes compared to those managed at home and those managed in the general 
medical wards. 
The results of the Cochrane Stroke Group systematic review conducted in 2013 were 
consistent with the results of the previous studies. The systematic review included 28 
randomized control trials which resulted in a total of over 5000 participants. The outcomes 
of stroke patients managed in stroke wards, mixed rehabilitation wards and general 
medical wards and those managed by a mobile stroke team were all compared. At 1 
year, patients managed in acute stroke units were found to be less likely to die, be 
dependent or require institutionalized care with odds ratios 0.81 (95% CI 0.69-0.94), 
0.79 (95% CI 0.68-0.9) and 0.78 (95% CI 0.68-0.89), respectively, compared to those 
stroke patients managed in general medical wards (Cochrane Stroke Group, 2013). 
Overall, the results comparing the organised stroke unit care to the less organised 
alternatives found that stroke units had favourable effects on the outcomes of stroke 
patients. 
These studies were conducted in high income countries and this led to debates about 
whether it was feasible to have stroke units in resource limited LMIC and achieve patient 
benefit. This question led to a small before-after study being conducted in a secondary 
hospital in South Africa (de Villiers et al., 2009). The study was conducted over 6 
months; in the first 3 months, data was collected on patients who were managed in the 
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general medical wards, and the second half of the study took place after the new stroke 
unit was set up. Patient outcomes for those managed in general medical wards were 
then compared to outcomes of those managed in the newly established acute stroke 
unit. Although the study had a small sample size of only 195 participants, the researchers 
found that a stroke unit could be established in a low resource setting with little impact on 
cost. The study also found that in-patient mortality was reduced in the stroke unit 
compared to the general medical ward, a reduction from 33% in the general medical 
ward to 16% in the stroke unit (p = 0.005). Though the study was small, participants 
not matched and the study duration short, the results suggested that positive patient 
outcomes could potentially be achieved from stroke units in poor resource setting. 
 
In summary, the evidence indicates that the acute and post-acute care of stroke patients 
by a MDT in a stroke unit results in favourable outcomes for stroke patients. There 
is also evidence to suggest that it is possible to set up these stroke units in resource poor 
settings and achieve benefits for the patients. The establishment of stroke units in 
LMIC such as South Africa can potentially have a positive impact on patient 
outcomes, reducing disability and morbidity rates. 
 
The evidence from studies such as these contributed to the development of the current 
South African guideline on the management of ischaemic strokes (Bryer et al., 2010). 
This guideline outlines the acute and post-acute management of ischaemic stroke 
patients including the components of an acute stroke unit and the minimum 
requirements for the different level of hospitals found in South Africa. However, since 
these national guidelines were established, no evaluation has been conducted on the 
services offered to ischaemic stroke patients in the country. This is all the more 
relevant as the quality of acute and post- acute care services are likely to affect patient 
outcomes after stroke. 
Therefore, the aim of this study is to evaluate the acute and post-acute care services 
for ischaemic stroke patients offered at level 1, 2 and 3 hospitals in the Cape Metro 
Health District and identify barriers to optimum stroke care in these hospitals. Using 
this information, cost effective models suitable for these hospitals may be 
recommended to overcome these barriers and optimize stroke care. Table 1 below 




3.2 Study design 
 
This will be a descriptive study comprised of semi-structured interviewer administered 
questionnaires, audits of hospital stroke management and a record review of ischaemic 
stroke patient discharge summaries. 
 
Table 1: Summary of the components of acute and post-acute stroke care used to 
assess quality in this study 
The components of acute and post-acute ischaemic stroke care used to assess the 
quality of care as per the South African guidelines 
1. Stroke unit – the presence of a geographically defined area in the hospital with dedicated 
beds for the management of stroke patients. 
2. Protocols for acute and post-acute management of stroke that focus particularly on the 
active management of physiological abnormalities to maintain homeostasis in ischaemic 
stroke patients. 
3. The presence of a MDT that conducts combined rounds. The MDT includes a medical 
doctor specialised or with a special interest in stroke care, nursing staff and at least one 
physiotherapist, occupational therapist, speech and language therapist, social worker, 
dietician and psychologist. The different health professionals that comprise the MDT 
will differ depending on the level of the hospital; secondary, regional or tertiary. 
4. Continued medical training on stroke care for all the health workers involved in the 
management of ischaemic stroke patients. 
5. Education of the patient and his/ her family on the causes and management of ischaemic 
stroke, both as an in-patient and out-patient. 
6. The use of the thrombolytic recombinant tissue plasminogen activator (rt-PA) for the 
management of ischaemic strokes at level 2 and 3 hospitals. 
7. The use of medication such as aspirin and drugs for hyperlipidaemia, hypertension and 
diabetes mellitus for secondary prevention. 
 
The semi-structured questionnaires will be administered through face to face interviews 
with health professionals who work in the sample of nine level 1, 2 and 3 hospitals in 
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the Cape Metro Health District. The study will be conducted in these hospitals because 
they have in- patient facilities and have the capacity to admit ischaemic stroke patients. 
After the face to face interviews have been completed, a retrospective review of data 
from computerized hospital patient discharge summaries will be used to describe the 
characteristics of patients, aged 18 years and older, admitted with ischaemic strokes at 
Groote Schuur Hospital, Cape Town from the 1st of August 2016 to the 31st of January 
2017. Only Groote Schuur Hospital patient discharge summaries will be used in this 
study because it has the most complete and accurate patient discharge summaries 
compared to the other hospitals. 
Table 2: Level 1, 2 and 3 hospitals in the Cape Metro Health District 
Level 1 (District) Level 2 (Regional) Level 3 (Tertiary) 
• Eerste River Hospital 
• False Bay Hospital 
• Karl Bremer Hospital 
• Khayelitsha Hospital 
• Mitchell’s Plain 
Hospital 
• Victoria Hospital 
• New Somerset 
Hospital 
• Groote Schuur 
Hospital 
• Tygerberg Hospital 
 
 
3.3 Study population 
 
The study population includes level 1, 2 and 3 hospitals in the Cape Metro health district. 
A sample of all 9 hospitals will be included in the study; six level 1 hospitals, one 
level 2 hospital and two level 3 hospitals. Table 2 above shows the list of the hospitals 
in the Cape Metro Health District that will be included in the study. 
3.4 Data collection 
 
All the data will be collected by the researcher, over a period of 10 weeks. From the 7 
level 1 and 2 hospitals that have been included in the study, 3 health professionals 
involved in the management of ischaemic stroke patients will be randomly selected 
from each health facility. The 3 health professionals will include; a medical doctor who 
works in the emergency department and a medical doctor and a nurse who manage 
ischaemic stroke patients in the internal medicine wards. From the 2 level 3 hospitals 
included in the study, 5 health professionals involved in the management of ischaemic 
stroke patients will be randomly selected from each hospital. The 5 health professionals 
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will include a medical doctor and a nurse who manage ischaemic stroke patients in the 
internal medicine wards, a doctor and a nurse who manage ischaemic stroke patients in 
the stroke units and a doctor who works in the emergency department. 
 
These randomly selected health professionals will be invited to participate in face to 
face interviews. The interviews will be conducted in English by the researcher at their 
respective health facilities. The participants will be interviewed one at a time in a 
comfortable secluded area and only one interview will be conducted for each 
participant. The interviews will be recorded using a digital audio recorder and 
questionnaire forms. The responses from the open ended questions will be transcribed 
from the digital audio recordings after the interviews and the responses from the closed 
ended questions will be filled out in the questionnaires during the interviews. 
 
The questionnaires that will be used during the semi-structured interviews with the 
doctors and nurses are attached in Appendix 3. These questions were designed to assess 
the different components of acute and post-acute ischaemic stroke care as contained in the 
national stroke guidelines and as listed in table 1. The responses from these 
questionnaires will be used to determine the quality of ischaemic stroke care in the 
different hospitals in the Cape Metro Health District. The interviews will also elicit 
information on any barriers to optimum care the medical doctors and nurses may 
encounter during their practice. The health professionals will also be given the 
opportunity during the interviews to give their suggestions on how these barriers to 
optimum stroke care could be overcome. 
 
Table 3 below shows the list of components that will be used to assess quality of acute 
and post-acute stroke care services in the level 1, 2 and 3 hospitals and also which 
of the components will be covered in the questionnaires with the different health 
professionals in assessing the presence, absence or degree of compliance to these 
components. 
After the semi-structured face to face interviews with the health professionals have 
been conducted at a particular hospital, an audit of the hospitals stroke 
management will be performed using the audit forms in Appendix 4 to verify some of 
the information that would have been provided during the interviews. These audit 
forms were adapted from the South African national stroke guidelines and contain the 
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minimum requirements for the different level of hospitals found in South Africa. There 
are 3 audit forms and these were specifically designed for the 3 different hospital levels. 
 
After the interviews and hospital audits have been completed, clinical data on 96 
ischaemic stroke patients admitted at Groote Schuur Hospital during the period from the 
1st of August 2016 to the 31st of January 2017 will be collected in a retrospective 
review of discharge summaries. The sample size of 96 ischaemic stroke patients is 
based on the anticipated prevalence of adherence to guidelines of 50%, 95% 
confidence interval and a precision of 10%. 
 
 
Table 3: The list of components that will be used to assess quality of acute and post-
acute stroke care services in the level 1, 2 and 3 hospitals and which health professional 
will have questions directed towards assessing the component 
 
Components of acute and post –acute stroke care 










1. Stroke unit – the presence of a geographically defined 
area in the hospital with dedicated beds for the 
management of stroke patients 
 
•  •  •  
2. Protocols for acute and post-acute management of 
stroke with special attention to active management of 
physiological abnormalities to maintain homeostasis 
 
•  •  •  
3.1. The presence of a MDT that conducts combined 
rounds.  
3.2. The MDT includes a medical doctor specialised or 
with a special interest in stroke care, nursing staff and at 
least one physiotherapist, occupational therapist, speech 
and language therapist, social worker, dietician and 
psychologist (this will depend on the health facility) 
 
•   •  
4. Continued medical training on stroke care for all the 
health workers involved in the management of stroke 
patients 
 
•   •  
5. Education of the patient and his/ her family on the 
causes and management of the stroke, as an in-patient  
 
•   •  
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6. The use of the thrombolytic recombinant tissue 
plasminogen activator (rt-PA) for the management of 
ischaemic strokes at level 3 hospitals 
 
•  •   
7. The use of medication such as aspirin and drugs for 
hyperlipidaemia, hypertension and diabetes mellitus for 
secondary prevention  
•   •  
 
Approximately 450 stroke patients are admitted at Groote Schuur hospital annually. 
Studies have found that ischaemic strokes are the most common, contributing about 
87% of cases, therefore, approximately 392 ischaemic stroke patients are admitted to 
Groote Schuur Hospital annually or about 196 ischaemic stroke patients in 6 months. 
Assuming that not all patients will have discharge summaries that are easily available, 
some patients will be under 18 years of age and other discharge summaries will be 
excluded based on the other exclusion criteria, 96 folders can be obtained for review over 
a 6 month period. 
 
Therefore,  96 selected patients who are 18 years and older admitted with a diagnosis of 
ischaemic stroke at Groote Schuur Hospital during the period from the 1st of August 
2016 to the 31st of January 2017 will be recruited. If the number of eligible discharge 
summaries is less than 120 but more than 96,  all the discharge summaries will be 
included. If the number of ischaemic stroke patient discharge summaries available is 
more than 120, a  s amp l e  o f  96  will be randomly selected in proportion to the number 
of cases by month. 
 
Patients will initially be identified using the nurse’s patient admission record book. 
The names and hospital numbers of all the patients with a provisional or definitive 
diagnosis of stroke admitted in both the acute stroke unit and the medical wards during 
the specified 6- month period will be collected. From this list, the patients’ 
computerized hospital discharge summaries will be reviewed and only those stroke 
patients found to have had an ischaemic stroke will be included. The conclusion that 
a patient had an ischaemic stroke ischaemic stroke will be based on the clinician’s 
management and diagnosis in the patient discharge summaries. In cases where a patient 
has had recurrent strokes during the study period, only the first admission occurring 
within the stated 6-month period will be included in the study. Variables that will be 
collected during the review of computerized stroke patient discharge summaries are 
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listed in table 4 below and in appendix 5. 
No interviewee names will be attached to the questionnaires or recorded on the digital 
audio recorder. Confidential i ty and anonymity wil l  be maintained through 
the removal of personal identifiers.  For the clinical data, unique patient 
identifiers will be generated for the list of ischaemic stroke patients collected. The list 
of names and hospital numbers of the ischaemic stroke patients will be kept in a 
password protected computer file separate from the clinical data collected and all this 
information will be accessible only to the researcher. 
 
Table 4: Description of the variables to be used in the review of ischaemic stroke patient 
discharge summaries 
Variable  Description of variable 
1. Age Age will be recorded in years and it will be the age of the 
patient at the time of admission 
2. Gender Male or female 
3. Duration of admission Duration of admission will be recorded in days and these 
will be counted from the first day of admission 
4. Admitting ward Admitting wards are either the acute stroke unit or the 
medical ward 
5. Co-morbidities The co-morbidities that will be searched for specifically 
are hypertension, diabetes mellitus and hyperlipidaemia 
6. Mandatory laboratory 
investigations 
These investigations should be conducted in every 
ischaemic stroke patient: 
i. Full blood count (FBC) 
ii. Urea and electrolytes (U + E) 
iii. Creatinine 
iv. Random blood sugar (RBS) or glucometer 
reading 
v. Erythrocyte Sedimentation Rate (ESR) or C-
reactive protein (CRP)  
 
7. Other mandatory 
investigations 
These investigations should be conducted in every 
ischaemic stroke patient:  
i. Electrocardiogram (ECG) 
ii. Chest x-ray (CXR) 
8. The use of recombinant 
tissue plasminogen 
activator (rt-PA) 




9. The use of medication 
 
i. Aspirin  
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such as aspirin and 
drugs for diabetes 
mellitus, hypertension 
and hyperlipidaemia for 
secondary prevention 
ii. Anti-hypertensive and hypoglycaemic medication 
and drugs for hyperlipidaemia prescribed for 
patients with hypertension, diabetes mellitus and 
hyperlipidaemia respectively 
10. Discharge Where the patient was discharged to;  
i. Home  
ii. An institution. If the patient was discharged to an 
institution, whether it was a hospital, 
rehabilitation centre or a hospice 
 
3.4.1 Inclusion criteria 
 
Health professionals with a minimum of six months experience in managing ischaemic 
stroke patients in their respective departments at the particular hospital will be invited to 
participate in the face to face interviews. It will be assumed that a doctor or nurse 
working for at least 6 months in the emergency unit or on a ward that admits ischaemic 
stroke patients has experience managing stroke patients. 
For the clinical data collection, only ischaemic strokes will be considered for this study. 
For an ischaemic stroke patient discharge summary to be included in the study, the 
patient will need to been admitted at Groote Schuur Hospital with indications of 
having suffered an ischaemic stroke or have a diagnosis of ischaemic stroke during the 
period between the 1st of August 2016 and the 31st of January 2017. For stroke 
patients with recurrent strokes during the 6-month period under study, only the first 
admissions during the specified period will be considered. Adult patients, 18 years and 
older at the time of admission, will be included.  
3.4.2 Exclusion criteria 
 
For the face to face interviews, the health professionals w i t h  l e s s  t h a n  6 months 
experience in their respective departments at that particular hospital will be excluded 
from the study. 
For clinical data collection, a patient with a haemorrhagic stroke, transient ischaemic 
attack or other neurological condition besides ischaemic stroke will be excluded from 
the study. Patient discharge summaries with insufficient detail on the type of stroke will 
also be excluded. Patients who are younger than 18 years of age at the time of admission 
20  
will be excluded from the study. 
3.5 Data analysis 
 
The data from the interviews, hospital audits and the review of ischaemic stroke 
patient discharge summaries from Groote Schuur Hospital will initially be analyzed 
separately. Thematic coding and analysis will be used for the data obtained from 
the interviews and hospital audits, and the coding for the discharge summaries has been 
outlined in appendix 5.1. The results obtained will then be compared to the minimum 
requirements listed in the audit forms in appendix 4, depending on whether the 
hospital is a level 1, 2 or 3 hospital. If responses from a questionnaire contradicts the 
results from an audit, more weight will be given to the results of the audit as these 
will be more objective compared to the questionnaire responses. Comparing the 
current acute and post- acute ischaemic stroke services offered in the different 
hospitals against the South African ischaemic stroke guidelines will help in 
determining the quality of stroke care services offered. These minimum 
requirements listed in appendix 4 were adapted from the South African guidelines 
for the management of ischaemic stroke. Table 5 below shows how the quality of 
ischaemic stroke care will be assessed for each of the components of stroke care that 
will be used for this study. 
 
For the numerical data; means and standard deviations or medians and inter-quartile 
ranges will be used to summarize the data and the decision about which measures are 
used will be determined by the distribution of the data. Categorical data will be 
summarized using frequency tables. Patterns in the data will be analysed using box and 










Table 5: How the quality of ischaemic stroke care will be assessed for each of the 
components of stroke care that will be used for this study 
The components of acute and post-acute 
ischaemic stroke care used to assess the 
quality of care  
Description of how quality will be 
assessed 
1. Stroke unit – the presence of a 
geographically defined area in the 
hospital with dedicated beds for the 
management of stroke patients. 
The presence of hospital beds dedicated 
specifically for stroke patients will be 
classified as fulfilling the requirements. 
2. Protocols for acute and post-acute 
management of stroke that focus 
particularly on the active management 
of physiological abnormalities to 
maintain homeostasis in ischaemic 
stroke patients. 
When written protocols are available on the 
ward and in the emergency department and 
these protocols include information on the 
active management of physiological 
abnormalities to maintain homeostasis in 
ischaemic stroke patients, this will be 
classified as fulfilling the requirements.  
3. The presence of a MDT that conducts 
combined rounds. The MDT includes a 
medical doctor specialised or with a 
special interest in stroke care, nursing 
staff and at least one physiotherapist, 
occupational therapist, speech and 
language therapist, social worker, 
dietician and psychologist. The 
different health professionals that 
comprise the MDT will differ 
depending on the level of the hospital; 
secondary, regional or tertiary. 
 
The combinations of health professionals in 
the MDT will depend on the level of the 
hospital. The hospitals meeting the 
minimum staff requirements for a MDT for 
their particular hospital level will be 
classified as fulfilling the requirements. 
4. Continued medical training on stroke 
care for all the health workers involved 
in the management of ischaemic stroke 
patients. 
The hospitals which have at least one tutorial 
meeting a week involving the management 
of ischaemic stroke patients as stated by the 
doctors and nurse during the interviews will 
be classified as fulfilling the requirements. 
 
5. Education of the patient and his/ her 
family on the causes and management 
of ischaemic stroke, both as an in-
patient and out-patient. 
The hospitals where there is evidence of 
patient and care giver education in the form 
of a checklist of topics that are discussed 
during these meetings will be classified as 
fulfilling the requirements. 
 
6. The use of rt-PA for the management 





Documentation of the use of rt-PA in the 
ischaemic stroke patient discharge 




7. The use of medication such as aspirin 
and drugs for hyperlipidaemia, 
hypertension and diabetes mellitus for 
secondary prevention  
i. In the interviews, if the doctors and 
nurses mention that during the 
discussions with the patients and 
caregivers, they discuss the use of 
medication in secondary prevention 
of an ischaemic stroke; this will be 
classified as fulfilling the 
requirements. 
ii. In the review of patient discharge 
summaries, the presence of a 
prescription for aspirin and/or 
medications for hypertension, 
diabetes mellitus or hyperlipidaemia 
will be classified as fulfilling the 
requirements. 
 
Any associations between 2 numerical variables will be tested using Pearson’s 
correlation coefficient or Spearman rank correlation, the test used will depend on the 
underlying distributions of each variable. The Chi-squared test or Fisher’s exact test will 
be used to test for any associations between categorical variables; the choice of test used 
will depend on the value of the expected frequencies in the cells of the contingency 
tables. Analysis of the data will be conducted using the statistical software STATA, 
version 14 (StataCorp. 2015). 
3.6 Limitations 
 
One of the limitations of this study is that some of the data relies heavily on what the 
health professionals say during the interviews. Some of the data can be verified using 
the hospital audits and patient discharge summaries but for some of the components of 
stroke care, only the responses made during the interviews will be used in the analysis. 
If there is missing data in the patient discharge summaries, the researcher will not seek 
to fill in information that is missing but will only use what is in the summaries during 
the analysis. When data is missing for a particular variable, that specific patient will be 






The timeline for the research study is summarized in table 6 below. 
 

















































         




The budget for this research project is summarized in table 7 below. 
 
Table 7: Budget for the research project 
 
Item Description Cost 
(ZAR) 
Quantity Total cost 
(ZAR) 
Stationery 1. Protocol 0.5/ page 69 pages 
(3 copies) 
34.50 
2. Participant information 
forms 
0.5/ page 15 pages 7.50 
3. Consent forms 0.5/ page 30 pages 15.00 
2. Interview transcripts 0.5/ page 300 pages 150.00 
3. Audit forms 0.5/ page 15 pages 7.50 
4. Data collection forms 0.5/ page 10 pages 5.00 
4. Literature review 0.5/ page 30 pages 15.00 
5. Journal article 0.5/ page 7 pages 3.50 
6. Binding 40/ copy 3 120.00 
Data storage USB drive 150 1 150.00 






4.1 Ethical considerations 
 
4.2 Ethical review 
 
Approval for the study will be obtained from the University of Cape Town Human 
Research Ethics Committee (UCT-HREC) in the Faculty of Health Sciences. Additional 
approval will be obtained from the Western Cape Department of Health and the level 1, 2 
and 3 hospitals in the Cape Metro Health District that will be included in the study. 
4.3 Risks 
 
This is a minimal risk study for the health professionals participating in the study. 
Every effort will be made to make the participants comfortable during the 
interviews. For the clinical data collection using the patient discharge summaries, there 
will be no direct contact with the stroke patients; information will be extracted from the 
computerised hospital patient discharge summaries. Hospitals that are found to not be 
adhering to the national guidelines will not incur any penalties. 
 
With both the interviews and review of discharge summaries, there is a risk of loss 
of confidentiality. However, no personal information of the participants or patients 
will be attached to the data during analysis or be published in the thesis or any other 
publications that will ensue from it. In addition, all the questionnaires, consent forms, 
recordings and data collection forms will be stored in a locked cupboard in the 
postgraduate room 5th Floor Falmouth Building at the University of Cape Town 
Health Sciences campus and any data stored in computer files will be password 
protected. The list of names and hospital numbers of the stroke patients will be kept in 
a password protected computer file separate from the clinical data collected in the data 




After all the interviews for a particular health facility have been completed, the 
health professionals interviewed will be provided with information on the current 
South African stroke guidelines. The stroke patients whose discharge summaries will 
be reviewed will not benefit directly from this study however the information 






The health professionals who will participate in the face to face interviews will not 
receive any compensation. 
4.6 Informed consent 
 
Informed consent will be obtained from the participants who will be invited to take part in 
the interviews. The participants will be informed about the objectives of the study, the 
benefits and the potential risks of taking part in the study and the measures that have been 
put in place to minimize these risks. They will also be informed that participating in 
the interviews is voluntary and if they were to choose not to continue participating at 
any time during the interview, there will not be any consequences for taking such an 
action. No consent will be sort from the patients whose discharge summaries will be 
reviewed as there will be no direct contact with these patients. 
4.7 Privacy and confidentiality 
 
There will be no personal identifiers attached to the questionnaires, audio recordings or 
data collection forms. The researcher will not collect any personal information such as 
names and addresses from the study participants during the interviews. The patient 
names and hospital numbers collected for the review of discharge summaries will be 
kept separate from the data collection forms and only the researcher will have access to 
them. 
All the questionnaires, the list of patient names and hospital numbers, data collection 
forms and consent forms will be kept in a locked cupboard at the University of Cape 
Town Health Sciences campus and any data stored in computer files will be password 
protected computer. Responses of participants who will be interviewed will be reported 
anonymously so that it will not be possible to match an individual’s response to a 
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Strokes are an important cause of disability in adults and the second leading cause of 
death globally (Brainin et al., 2007, Mohd Nordin et al., 2014). They are a global 
public health problem and focusing on prevention strategies as well as good quality 
stroke care is important. 
This is a brief analysis of the literature available on stroke care in different settings 
around the world with a focus on low and middle income countries (LMIC). Analysing 
the literature on stroke care in other LMIC can assist in describing the type and 
understanding the quality of stroke care in the different hospitals in the Cape Metro 
Health District in Cape Town, South Africa. 
In 2010, the South African guideline for the management of ischaemic stroke (Bryer et 
al., 2010) was published and this outlined the components of care recommended at 
the different hospital levels. Although the national guideline has been in place since 
2010, it is unclear as to the extent to which the guideline has been implemented in the 
hospitals, if at all. 
Publications for this literature review were found using Pubmed, Cochrane, Google 
scholar and Scopus. The following keywords were used “acute cerebrovascular 
accident” OR “stroke” OR “cerebral stroke” OR “cerebrovascular stroke” OR “little 
stroke” OR “brain attack” OR “acute cerebral accident” OR “ischaemic stroke” OR 
“ischemic stroke” AND “care” OR “management” OR “treatment” OR “rehabilitation” 
AND “low and  middle income countries” OR “third world countries” OR “developing 
countries”. 
1.2 Definitions 
The World Health Organization clinical definition of stroke is "rapidly developing signs 
that result from a focal or global disturbance of cerebral function, with symptoms lasting 
24 hours or longer or leading to death with no apparent cause other than of vascular 
origin" (Krishnamurthi et al., 2014, Norrving and Kissela, 2013). 
 
Strokes can be broadly classified into ischaemic and haemorrhagic. Ischaemic strokes 
are caused by thrombi or emboli obstructing the blood vessels supplying the brain. They 
are the most common, accounting for 87% of all strokes (Summers et al., 2009). 
Haemorrhagic strokes are less common and result from rupturing of weakened blood 
30  





Figure1: Mechanism of brain injury in ischaemic stroke (sourced from: The Internet 
Stroke Center      (www.strokecenter.org/patients/about-stroke/ischemic-stroke/)) 
 
Strokes usually present as a sudden onset of neurological deficits which can present 
as paralysis, weakness or loss of sensation involving the face and/or limbs. They 
can also present as disturbances in speech or vision and other defects of higher cortical 
function. The signs and symptoms can be indicative  of the area of the brain that has 
been affected. However, some strokes can be silent, presenting as deterioration in 
cognitive function, changes in behaviour or disorders of gait and balance with no 
apparent neurological symptoms (Lindsay et al., 2014). 
 
1.3 Stroke burden and mortality 
The past 4 decades have seen a shift in the incidence rates of stroke in both high and 
LMIC. The age adjusted incidence rates of strokes in high income countries (HIC) 
(Mellon et al., 2016) have decreased by 42% from 163 per 100 000 person-years in 
the period 1970-1979, to 94 per 100 000 person-years from 2000-2008 whereas LMIC 
have seen an increase of more than 100%, from 52 per 100 000 person-years to 117 
per 100 000 person-years during the same time periods (Feigin et al., 2009, Mendis, 
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2013). This increase has been suggested to be a result of factors such as poor access 
to healthcare, the rising life expectancy and lifestyle changes (Bonita and Beaglehole, 
2007, Feigin et al., 2014). 
 
The global burden of disease due to strokes continues to be heavily influenced by 
the contribution from LMIC. In 2010, globally, strokes were responsible for 
approximately 5.9 million deaths, 33 million prevalent cases and 102.2 million 
disability adjusted life years (DALYs) lost, of which 71%, 52% and 78%, 
respectively, were from LMIC (Feigin et al., 2014). The proportion of patients dying 
from strokes in the LMIC was disproportionately larger and the patients younger 
compared to those in HIC (Strong et al., 2007, Sajjad et al., 2013). Having such a large 
proportion of the economically viable younger population dying as a result of stroke 










Strokes in South Africa, like in many other LMIC, are a major health issue and have 
resulted in significant death and disability. In 2008, the incidence of stroke in males and 
females was found to be 465 and 615 per 100000 population, respectively, and the 28 
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day fatality incidence, 155 and 204 per 100000 population, respectively (Bertram et 
al., 2013). The burden of disease due to stroke was estimated to be 564000 DALYs, of 
which 17% was years lived with a disability (Bertram et al., 2013). According to 
Statistics South Africa, in 2013, cerebrovascular diseases were ranked fourth in the 
top ten leading causes of death and accounted for approximately 4.9% of deaths 
(Statistics South Africa., 2013) 
 
Without interventions, the stroke global burden of disease is estimated to continue to 
rise. The increase in incidence and mortality is expected to rise faster in the LMIC and 
therefore continue to be higher than in HIC (Strong et al., 2007). It is estimated that by 
2030, there will be between 7.8 to 12 million deaths, 23 million incident cases, 70 million 
prevalent cases and over 200 million DALYs lost annually worldwide (Feigin et al., 
2014, Addo et al., 2012). Interventions that combined effective prevention strategies 
and stroke care have been found to lower incidence and mortality rates attributed to 
strokes in HIC (Feigin et al., 2014), therefore implementing such interventions could 
possibly lower the burden of disease due to stroke in LMIC. 
 
2.1 Stroke care 
2.2 Acute stroke care 
It is recommended that in the acute phase, stroke patients be managed in a stroke unit 
by a multidisciplinary team (MDT) which “should ideally include a stroke physician, 
nursing staff, occupational therapist, physiotherapist, speech pathologist, dietician, social 
worker and where possible a psychologist” (Bryer et al., 2010). However, in many 
LMIC, there are not enough stroke units (de los Ríos la Rosa and Broderick, 2013) and 
stroke patients that make it to the hospital are often managed in general medical wards 
(GMWs). The main aims in the acute phase of stroke care include maintaining 
homeostasis, early patient mobilisation, preventing complications and at specialised 
centres (stroke units), when indicated, reperfusion of the ischaemic area of the brain can 
be attempted (Langhorne et al., 2012). 
 
2.2.1 Reperfusion therapies in acute ischaemic stroke 
2.2.1.1 Recombinant tissue plasminogen activator (rt-PA) 
Rt-PA is a drug that works by breaking down clots in blood vessels to achieve 
reperfusion in the ischaemic area of the brain (Wechsler, 2011). Meta-analysis on 
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stroke patient outcomes found that when rt-PA was administered within 4.5 hours of 
symptom onset, the patients had better outcomes irrespective of the severity of the stroke 
or their age (Emberson et al., 2014). The meta-analysis also found that the benefits of 
rt-PA outweighed the increased risk of developing intracranial haemorrhage during 
the first few days of therapy. Due to these potential risks, rt-PA should only be 
provided in stroke centres with access to protocols for drug administration, early brain 
imaging, laboratory facilities and neurosurgical advice, as well as health providers 
trained to administer this drug. 
 
2.2.1.2 Emerging therapy: Endovascular clot retrieval (mechanical thrombectomy) 
 
 
Mechanical thrombectomy the removal of a blood clot using a device inserted into the 
blood vessel to restore circulation to the affected area of the brain (Kim et al., 2006). It 
is indicated in patients with a major ischaemic stroke due to proximal vascular 
occlusion, (Bryer et al., 2010). Like rt-PA, this intervention is time dependant and can 
only be performed within 6 hours of the onset of stroke symptoms (Smith and 
Schwamm, 2015). Current guidelines recommend that this form of therapy be 
performed only by specialists in centres with access to computerized tomography 
angiograms (Bryer et al., 2010). It is also recommended that ischaemic stroke patients 
meeting the criteria for rt-PA should first receive it then have mechanical 




2.1.2 The stroke unit model of care 
A stroke unit is a “geographically defined”, organized area in the hospital where 
stroke patients are managed by a dedicated MDT (de Carvalho et al., 2011, Svendsen et 
al., 2009, de Villiers et al., 2009). The stroke unit model of care is one of the most 
important and effective aspects of acute stroke care. In addition to a MDT that conducts 
regular ward rounds; components of a stroke unit include ongoing stroke training 
programs for all medical professionals involved in stroke management and standardized 
protocols for acute and post- acute stroke care, all of which ensures the standardization 
of care (Bryer et al., 2010). Other important components include early mobilisation and 
rehabilitation of the patients and early involvement of the patient’s caregivers. 
Involvement of the patient’s caregivers in the multidisciplinary meetings, nursing care 
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and rehabilitation is particularly helpful in resource poor settings where caregivers can 
be more actively involved in the rehabilitation process and help the patient adhere 
to secondary prevention recommendations after discharge (Langhorne et al., 2012). In 
acute stroke units, regular meetings (at least once a week) between the medical staff 
and the patients and their relatives should be conducted to discuss management, 
progress and discharge plans (Young and Forster, 2007). The combined effort from the 
different disciplines as well as the caregivers results in comprehensive and effective 
care in stroke units affording the patients, the best possible outcome. 
There is robust evidence to show that the stroke unit model of care has favourable effects 
on patient outcomes; reduced odds of dying, being dependent or requiring 
institutionalized care (Group, 2013, Indredavik et al., 1991, Kalra et al., 2005, 
Langhorne et al., 1993, Stroke Unit Trialists’ Collaboration, 1997, Sun et al., 2013). 
Many of the randomized controlled trials (RCTs) that demonstrated the effectiveness of 
stroke units were conducted in HIC. Given the differences in the healthcare systems 
and economic environments between the high and LMIC, there was debate on how 
practical and effective stroke units in LMIC would be. Subsequently, studies were 
conducted examining the effectiveness of stroke units in LMIC and if it was feasible to 
establish them in resource poor settings. 
One of these studies was conducted in Thailand and included patients admitted into a 
hospital over 2 years (2001-2003) (Suwanwela et al., 2007). In this study, patients 
managed in stroke units and short term wards were found to have better outcomes and 
had less overall complications (16%) compared to  those  managed  in the  GMWs 
(26%) (p<0.001) (Suwanwela et al., 2007). 
 
Similarly, in a cohort study (retrospective and prospective) conducted in India,  it was 
found that in-hospital mortality and complications were lower in patients managed in 
stroke units compared to those in the GMWs though there were some differences in 
participant diagnosis and interventions (Pandian et al., 2011).  In this study, there were 
201 participants in the intervention arm (stroke units) and 202 in the standard of care 
arm (general medical wards) with a diagnosis of either ischaemic or haemorrhagic 
stroke. In the stroke unit and GMWs arms of the study, there were 141 and 128 
ischaemic stroke respectively, and 60 and 74 haemorrhagic stroke respectively. The 
participants in the stroke units were found to have a statistically significant (p<0.0001) 
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reduced mortality (11.9%) compared to the GMWs (47%) and also reduced 
complications, 42.2% in the stroke unit and 64.8% (p<0.0001) in the GMWs 
(Pandian et al., 2011). In the stroke unit, more participant risk factors were identified and 
more participants were initiated on secondary prevention drugs on discharge compared to 
those in the GMWs. Unlike the previous study, they found that participants had 
longer hospital stays in the stroke unit (mean: 9.4 days +/- 6.7) compared to the GMWs 
(mean: 7.7 days +/- 8.1) and this was attributed to the hospital’s longer rehabilitation 
programme (Pandian et al., 2011). 
 
The limitation of both the Thai and Indian studies is that they were conducted in 
urban hospitals and these hospitals are not representative of all the hospitals in these 
countries. Significant differences in the availability of resources exist among 
different health institutions within LMIC and this could have an impact on the success of 
the stroke units. 
 
A 2002 South African study addressed the question about the feasibility of stroke 
units in resource limited environments. The prospective cohort study conducted in a 
district hospital in South Africa indicated that a stroke unit could be established at 
an under-resourced community hospital without incurring additional costs. This study 
was conducted over a 6- month period; during the first 3 months, data was collected 
from stroke patients managed in the GMWs (n=94), then over the next 3 months, data 
collected from those admitted into the newly established stroke unit (n=101). The 
researchers found that a stroke unit could be established in a low resource setting 
with little impact on cost and in-patient mortality was reduced from 33% in the general 
medical ward to 16% in the stroke unit (p = 0.005). Though the study was small 
(n=195), the participants in both arms of the study not matched and the study duration 
short, the results suggested that positive patient outcomes could potentially be achieved 
from stroke units in a poor resource setting. (de Villiers et al., 2009). 
 
In summary, the evidence indicates that the acute and post-acute care of stroke patients 
by a MDT in a stroke unit results has favourable outcomes for patients, in both high 
and LMIC. There is also evidence to suggest that it is possible to set up stroke units 
in resource poor settings and achieve patient benefit. Stroke units in LMIC such as 
South Africa can potentially have a positive impact on patient outcomes and reduce 
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disability and morbidity rates. Despite the robust evidence on the efficacy of stroke units, 
many hospitals in the public healthcare sector in South Africa and many other LMIC do 
not have stroke units (Sposato et al., 2008). 
 
2.2 Post-acute stroke care 
 
 
The post-acute phase of stroke care mainly involves secondary prevention and 
rehabilitation. Secondary prevention strategies aim to prevent the recurrence of stroke 
and this is important because stroke survivors have an increased risk of developing 
another stroke compared to the general population (Mohan et al., 2011). The aim of 
rehabilitation is to obtain maximum function in patients through a process that 
involves maximizing body movement, function and activities, all of which have been 
shown to increase patient independence (Bernhardt and Cramer., 2013). 
 
2.2.1 Secondary prevention 
Secondary prevention strategies that address the identification and management 
(medical, surgical and behavioural) of risk factors are important in the post-acute phase 
of stroke care. Stroke risk factors can be classified into modifiable and non-
modifiable. Modifiable risk factors such as cigarette smoking, unhealthy diets and 
diseases like hypertension, can be altered (Mendis., 2013). In contrast, non-
modifiable risk factors, such as age, gender and ethnicity cannot be altered. 
Controlling modifiable risk factors can reduce the risk of stroke recurrence. A recent 
study found that 17 common modifiable risk factors accounted for 90.5% of the 
global burden due to stroke (DALYs); 91.1% in the LMIC and 89.3% in HIC (Feigin et 
al., 2015). There has been a rise in the prevalence of modifiable and non- modifiable 
risk factors in LMIC and this has been attributed to the rising aging populations, 
globalization and urbanization (Mendis, 2013). 
 
2.2.1.1 Modifiable risk factors 
 
Hypertension is the most common modifiable risk factor and is responsible for over half 
of the global stroke deaths (Feigin et al., 2015) and treating hypertension could 
result in an estimated risk reduction of up to 40% (Sacco et al., 2006, Tibazarwa and 
Damasceno, 2014). Treating hypertension as well as educating the patients regarding 
the importance of maintaining and complying with medication could significantly reduce 
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the risk of stroke. 
The administration of HMG-CoA reductase inhibitors (statins) to lower low density 
lipoproteins and total cholesterol are important in secondary prevention of stroke (Bryer 
et al., 2010). Studies have found that in secondary prevention, statins reduce the risk of 
stroke by 18% and mortality due to stroke by 13% (Rothwell et al., 2011). Statins in 
ischaemic strokes have also been found to have neuroprotective effects which limit 
damage, improve recovery and prevent early recurrence of stroke (Fisher and Moonis, 
2012, Bryer et al., 2010). 
 
Another important risk factor is diabetes mellitus; maintaining glucose control is an 
important aspect of management and secondary prevention. Maintaining near normal 
glucose levels can potentially reduce the risk of stroke recurrence (Bryer et al., 
2010). Hyperglycaemia is associated with increased morbidity and poor brain recovery 
(Baker et al., 2011). 
 
The patients’ adherence to medication combined with lifestyle changes can reduce the 
risk of stroke recurrence. The combined lifestyle and behavioural risk factors were 
responsible for 74.2% of DALYs of the global contribution of modifiable risk 
factors to the burden of disease due to stroke (Feigin et al., 2015). Lifestyle and 
behaviour modifications such as smoking cessation, increased physical activity and 
healthier diets can help to reduce the risk of stroke recurrence. 
 
2.2.1.2 Anti-platelet drugs 
 
Aspirin is an anti-platelet agent recommended for use in secondary prevention of non-
cardio- embolic ischaemic strokes (Sandercock et al., 2014). Evidence suggests that 
when aspirin should be commenced early after an ischaemic stroke has occurred and 
this results in a reduction in recurrence of ischaemic events (CAST., 1997, 
Sandercock et al., 2014). 
Clopidogrel is another anti-platelet drug that can be used in secondary prevention of 
ischaemic stroke. There is evidence to indicate that it is marginally more effective 
than aspirin, however, the effect of secondary prevention with clopidogrel was found to 
be more marked in diabetic patients with ischaemic stroke (Shulga and Bornstein, 
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2011). The limitation of clopidogrel is that it is more expensive than aspirin and the 
maximum platelet activity is delayed by about 4 or 5 days (Shulga and Bornstein, 2011). 




Vitamin K antagonists such as warfarin have been found to be significantly more 
effective than aspirin in secondary prevention of cardio-embolic ischaemic stroke, for 
example, due to atrial fibrillation (Shahpouri et al., 2012). Like warfarin, the newer 
direct oral anticoagulants (DOAC), have been found to be effective in preventing 
recurrence of cardio-embolic stroke. They have the added advantage of not requiring 
regular monitoring and having less drug and food interactions than warfarin (Gomes et al, 
2013). However, these DOAC are more expensive and this has limited their use in 





Rehabilitation in stroke patients involves a combination of goal oriented intervention 
therapies that are aimed at maximizing function (Quinn et al., 2009). This process helps 
to alleviate the symptoms of the various disabilities that occur as a result of stroke. A 
variety of specialised health professionals (rehabilitation team) are involved in 
providing the different forms of therapy required by the stroke patients. 
 
A rehabilitation stroke team is comprised of physiotherapists, occupational therapists, 
speech and therapists, social workers, psychologists and dieticians as well as nurses 
and medical doctors with experience in rehabilitation processes (Langhorne and 
Duncan, 2001). The absence of rehabilitation in the care of stroke patients results in 
more frequent re- hospitalizations, reduced quality of life and a deterioration in 
function (Mohd Nordin et al., 2014). The inclusion of a rehabilitation team in the 
management of stroke in the stroke unit is associated with improved patient recovery and 
reduced disability and  dependency (Langhorne and Duncan, 2001, Mendis, 2013, 
Mohd Nordin et al., 2014, Bernhardt and Cramer, 2013). 
It is recommended that rehabilitation be initiated as soon as possible after the acute 
stroke patient has been stabilized (Wissel et al., 2013, Quinn et al., 2009). Intensive 
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task specific rehabilitation intervention strategies in the acute stages of care have been 
found to be effective in the management of stroke patients as they impact on the level 
of function on discharge (Teasell and Kalra, 2004, Hanger et al., 2010). A study on 
elderly stroke patients found that those with a lower level of function on discharge 
were more likely to require institutional care and were also more likely to die during 
the follow-up period (Hanger et al., 2010). Therefore, maximizing functional ability 
through rehabilitation in the acute and post- acute phase has a significant impact on the 
stroke patients’ quality of life and risk of dying. 
 
Rehabilitation should continue after discharge at various facilities that may include 
outpatient hospital and community based rehabilitation centres, long term care 
facilities, rehabilitation hospitals and home based care (Wissel et al., 2013, Quinn et al., 
2009). The aims of long term rehabilitation are to reintegrate the patient into society; 
participating in daily activities and functioning as an independent individual. The 
intensity and frequency of outpatient rehabilitation is usually inadequate and this has 
an impact on patient recovery (Rhoda et al., 2014, Mohd Nordin et al., 2014). In South 
Africa and many other LMIC, there is frequently an interruption of services between 
inpatient care and outpatient or community care and a disruption in the continuation of 
care after discharge. 
 
The decision as to where the patient will receive optimal rehabilitation following 
discharge forms part of the discharge planning process involving the patient, family 
and MDT. The decision will depend not only on patient need but also on the available 
resources; the demand for beds in rehabilitation hospitals often exceeds supply. 
 
2.3.1 The role of rehabilitation intervention strategies 
 
Physiotherapy is one of the first forms of rehabilitation that an acute stroke patient 
receives and initially involves positioning, early mobilisation and mobility (Langhorne 
et al., 2011). The objective of physiotherapy in the post- acute phase is to improve 
movement, balance and gait (Langhorne et al., 2011, Van Peppen et al., 2004). 
Meta-analysis found that stroke patients who received physiotherapy had better 
outcomes and reduced incidence of complications associated with prolonged bed rest 
such as pressure ulcers and deep vein thrombosis, compared to those who did not 
receive physiotherapy (Quinn et al., 2009, Van Peppen et al., 2004). 
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Following a stroke, patients may also develop impairments in swallowing and speech 
(aphasia and dysarthria), requiring early assessment and intervention by a speech and 
language therapist (Langhorne et al., 2011). Failure to correctly examine and manage a 
stroke patient with swallowing difficulties can lead to complications, such as aspiration 
pneumonia which can contribute significantly to patient outcomes and mortality 
(Langhorne et al., 2011). 
Occupational therapy improves daily living activities by maximising the patient’s function 
in their specific environment (Quinn et al., 2009). Langhorne et al, 2011, suggests that 
occupational therapy be provided not only for patients with impairments in motor 
function but also for those with cognitive impairment. A systematic review of 
community based occupational therapy studies found that stroke patients who 
received occupational therapy derived positive effects on activities of daily living and 
these effects were more pronounced in older patients and those where targeted 
interventions were implemented (Quinn et al., 2009). 
Other important forms of rehabilitation include the input by dieticians and 
psychologists. Feeding can be a problem in stroke patients due to the associated 
difficulties in swallowing and communication, which can result in malnutrition over 
time. Malnutrition is common in stroke patients but this can be prevented by the early 
intervention of dieticians, making it important to properly manage the patient’s diet and 
feeding (Mosselman et al., 2013, Quinn et al., 2009). 
Depression is also common in stroke patients and in many cases this goes 
undiagnosed or inadequately managed (Hackett et al., 2008). This can negatively impact 
the patients’ recovery and quality of life, highlighting the contribution of 
psychologists in managing depression and other psychological problems that may 
accompany stroke (Quinn et al., 2009). 
3.0 Gaps in stroke care in South Africa 
 
The evidence from studies such as these contributed to the development of the current 
South African guideline on the management of ischaemic strokes (Bryer et al., 2010). 
These guidelines outline the acute and post-acute management of ischaemic stroke 
patients and the proposed minimum requirements for the different level of hospitals in 
South Africa. However, since this guideline was established, no evaluation has been 
conducted on the services rendered to ischaemic stroke patients in the country’s 
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hospitals. Such an evaluation is all the more relevant as the quality of acute and 
post-acute care services are likely to significantly affect patient outcomes after stroke. 
Before programs to establish new stroke units in a LMIC can be developed, it is 
important to first assess the quality of care being provided to the stroke patients, 
identify any challenges and barriers to optimum care and then incorporate these findings 
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Background: Strokes are an important global cause of disability and death in adults, 
particularly in low and middle income countries. In South Africa, like in many other low 
and middle income countries; stroke is an important public health problem. 
Objectives: To describe the acute and post-acute ischaemic stroke services offered to 
ischaemic stroke patients in level 1, 2, and 3 hospitals in the Cape Metro Health 
District, compare these services to the national guideline and identify any barriers to 
optimum stroke patient care. 
Methods: The study design was descriptive involving semi-structured interviewer 
administered questionnaires, audit of hospital investigations, and a review of 
ischaemic stroke patient discharge summaries. The population included six level 1, one 
level 2 and 2 level 3 public hospitals. Data collected were compared to 
recommendations in the South African national stroke guideline. 
Results: A total of 28 participants from 8 hospitals were recruited for the interviews; 
10 doctors and 10 nurses from general medical wards and stroke units and 8 doctors 
from emergency units. In the two Stroke Units (SUs) (6 beds each), at the level 3 
hospitals, the doctors and nurses had access to protocols, diagnostic investigations, 
recombinant tissue plasminogen activator and had comprehensive multidisciplinary team 
meetings. Most of the ischaemic stroke patients were admitted in the general medical 
wards of level 1, 2 and 3 hospitals; however, the level of care in these facilities was not 
homogenous. Most level 1 and 2 hospitals experienced difficulties transferring patients to 
higher levels of care and did not have protocols to guide their management, continued 
medical training programs in stroke care or access to some diagnostic investigations. 
Some of the challenges that were highlighted include patient delays, inadequate stroke 
education among health professionals, limited access to diagnostic investigations and 
shortage of staff and beds. 
Conclusion: The two SUs at the level 3 hospitals adhered most closely to the 
recommended South African national guideline. Variations in the level adherence 
existed in the general medical wards in level 1, 2 and 3 hospitals. Factors such as a 
shortage of staff, limited access to diagnostic investigations and patient delay, influenced 
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the level of adherence to the guideline. Recommendations or further research include 
implementing interventions to alleviate the challenges highlighted in this study and 






Strokes are an important global cause of disability and death in adults, particularly in low 
and middle income countries (LMIC) (1-3). The past 4 decades have seen a shift in the 
incidence rates of stroke in both high income countr ies (HIC) and LMIC. The age 
adjusted incidence rates of strokes in HIC  (4) have decreased by 42% between the 
periods 1970-1979 and 2000-2008 whereas LMIC have seen an increase of more than 
100%, from 52 per 100 000 person-years to 117 per 100 000 person-years during the 
same time periods (5, 6). In South Africa, like in many other LMIC, stroke is an 
important public health problem. In 2013, cerebrovascular diseases were ranked fourth in 
the top 10 leading causes of death in South Africa (7). 
Interventions that combine prevention strategies and stroke care have been found to 
reduce the incidence and mortality rates (8) The management of acute stroke patients in a 
stroke unit (SU) and by an organised multidisciplinary team (MDT) has been found to 
impact positively on outcomes (9, 10). There is robust evidence to show that the stroke 
unit model of care has favourable effects on patient outcomes; reduced odds of dying, 
being dependent or requiring institutionalized care (11-16). 
Drawing on results from all these studies, the South African guideline for the management 
of stroke attack was published (17). However, since the guideline was published in 2010, 
no evaluation has been conducted to assess the degree to which the guideline is 
being applied in the hospitals, if at all. The objectives of the study were to describe 
the acute and post-acute ischaemic stroke services offered to ischaemic stroke patients in 
level 1, 2, and 3 hospitals in the Cape Metro Health District (CMHD), compare these 




This study design was descriptive involving semi-structured interviewer administered 
questionnaires, audits of hospital management, and a review of ischaemic stroke 
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patient discharge summaries. The population included all level 1, 2 and 3 public hospitals 
(n= 6, 1 and 2 respectively) with in-patient facilities in the CMHD and all the hospitals 
were sampled. 
From each of the hospitals, 3 health professionals were randomly selected to participate in 
the interviews; 1 doctor and 1 nurse each from the general medical wards (GMWs) and 1 
doctor from the emergency unit (EU). For the level 3 hospitals, in addition to the 3 health 
professionals previously mentioned, 1 doctor and 1 nurse from each of the SUs were 
randomly selected to participate in the interviews. Thus, for each of the level 1 and 
2 hospitals, there was a total of 3 health professionals and for each of the level 3 
hospitals, a total of 5. The questionnaires had a combination of open-ended, closed-
ended and scaled questions (Likert scale). After the interviews, an audit of hospital 
stroke management was conducted at each hospital. 
The review of patient discharge summaries (first admissions) was only conducted at one 
level 3 hospital, GSH, because it had the most complete discharge records. A total of 145 
discharge summaries, for patients 18 years and older, admitted over a 6-month period 
(1stof August 2016 to 31st of January 2017), were collected. From these, 96 were 
randomly selected for the analysis. The sample size of 96 ischaemic stroke patients 
was based on the anticipated prevalence of adherence to guidelines of 50%, 95% 
confidence interval and a precision of 10%. The variables recorded include age, gender, 
admitting ward, co-morbidities, laboratory and radiological investigations, whether or 
not medication for secondary prevention was prescribed and whether they were 
discharged home or to an institution. 
 
All the data collected was then compared to pre-selected recommendations in the 
national stroke guideline. These recommendations were selected as they included most 
of the minimum requirements stipulated for each level of care (level 1, 2 and 3 
hospitals) in the guideline. Data from the level 3 hospital, GSH, was triangulated using 
the interviews, audit and the patient discharge summaries. 
3.0 Results 
 
All the data was collected over a 5-month period from February to June 2017. A total of 
28 participants from 8 hospitals were recruited for the interviews; 10 doctors and 10 nurses 
from the GMWs and SUs units and 8 doctors from the EU. One level 1 hospital was 
not able to participate in the study and no doctors or nurses were recruited from this 
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facility. 
Most of the doctors from the wards (60%) and EU (75%) were medical officers and the 
rest were medical registrars. For the nurses, most were registered nurses (70%) and the 
rest were either enrolled nursing assistants or enrolled nurses. The median time since 
qualifying for the ward doctors, ward nurses and EU doctors were 7 years (Inter-quartile 
range (IQR): 6.3 to 9), 19 years (IQR: 5.3 to 26) and 5.5 years (IQR: 3.7 to 7.5) 
respectively and the time since they started managing stroke patients was 2.25 years (IQR: 
1.3 to 3), 12 years (IQR: 2 to 15) and 0.84 years (IQR: 0.7 to 2.3) respectively. 
 
Of the 96 patient discharge summaries, 32% were admitted in the SU and of these 48% 
were female, 55% were hypertensive, 16% were diabetic and 13% had 
hyperlipidaemia. Those admitted in the SU had a median age and median admission 
duration of 50.3 years and 16 days, respectively (table 2). 
Table 1: Characteristics of sample of ischaemic stroke patients admitted at GSH 
 
 SU  (n=31) GMWs (n=65) 
 Median % Median % 
Females  48  52 
Age (Years) 50.3 (IQR 38.6 to 62.9)  64.3 (IQR 57.3 to 72.2)  
Duration of admission 
(days) 
 
16 (IQR 8 to 21) 
  
10 (IQR 6 to 13) 
 
Hypertension  55  80 
Diabetes Mellitus  16  37 
Hyperlipidaemia  13  11 
 
 
Table 2 below illustrates the results in relation to the pre-selected recommendations 









Table 2: Comparison of results to the national guideline (11) 
 
Recommendations (11) Study results 
3.1. Ongoing training for health professional involved 
in stroke care 
Of all 28 health professionals; 
• 16 reported having received some training in stroke care since qualifying and of these, most were as part of 
broader programs such as courses in acute emergency medicine, internal medicine and neurology training, 
Advanced Cardiac Life Support (ACLS) and in-service training, refresher courses and workshops. 
• Only 1 participant reported having completed an examinable stroke course 15 years prior 
• Of the 12 health professionals who had not received any training, 6 were nurses 
 
Out of the 20 doctors and nurses working in the GMWs and SUs; 
• 8 reported no scheduled seminars on stroke management 
• Of the 12 who reported having scheduled seminars, 2 reported having tutorials focused on stroke management at 
least twice a week while the rest had seminars where all medical conditions, including strokes were discussed 
• The scheduled seminars were in the form of case presentations, consultant ward rounds, academic meetings, 
journal clubs and nursing seminars. 
3.2.1 Protocols for the acute and post-acute 





• Protocols  for  referral  and  transfer  of  selected 
stroke patients to a level 2 or 3 hospital 
• 19 out of the 28 health professionals reported not having any protocols to refer to in the wards and EU 
• Those who reported having protocols were from 4 hospitals; one level 1, one level 2 and both level 3 hospitals 
• Of those who reported having protocols available, most strongly agreed that the protocols (commonly located in 
doctor’s offices, resuscitation area, nurse’s stations or front desk in the wards), were easily accessible to those 
who needed to use them 
 
• None of the EU doctors in level 1 and 2 hospitals reported having any protocols for upward referral of patients 
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• Use of the National Institutes of Health Stroke 
Scale (NIHSS) – assessment tool that can be used 
to grade severity of stroke, predict patient 
outcomes and determine eligibility  for 
recombinant tissue plasminogen activator (rt-PA) 
• 6 out of the 8 EU doctors agreed that strokes were treated as an emergency; however, most reported that this was 
dependent on whether the stroke patient presented within the window for reperfusion therapy or not. If not, they 
were not managed as emergencies but would receive urgent treatment 
 
 
• 9 out of the 18 doctors agreed that they were familiar with the NIHSS and of those, 8 either disagreed or 
strongly disagreed that each stroke patient was scored using NIHSS 
• 3 doctors reported only using it to grade severity in acute stroke patients who qualified for rt-PA 
3.2.3 The time interval from diagnosis to transfer to 
higher level hospitals (level 1 and 2) or from 
diagnosis to obtaining an interpreted Computerized 
Tomography (CT) scan 
• The EU doctors at level 1 and 2 hospitals reported the time period between making a clinical diagnosis of an 
acute stroke and them transferring the patient to a level 3 hospital was between 20 minutes and 12 hours 
• The time interval was dependent on how quickly the ambulance services could despatch a vehicle to the patient. 
• The level 3 hospital doctors reported that the majority of patients who arrived within the window for rt-PA had 
an interpreted CT scan within 30 minutes of arrival. 
• For the patients who arrived at hospitals with CT scan facilities, outside the window for rt-PA, the time interval 
from diagnosis to obtaining an interpreted CT scan ranged from a few hours up to 2 days. 
3.2.4 Swallow test • Out of the 18 nurses and EU doctors, 72% either agreed or strongly agreed that swallow tests were routinely 
performed on patients before they were allowed to eat or drink 
• Speech and language therapists were reported as often being responsible for formally performing swallow tests, 
followed by doctors and then nurses 
• Four respondents reported physiotherapists, occupational therapists and dieticians as being responsible for 
performing swallow tests at their hospitals 
• Even though doctors and nurses were among those who were responsible for performing swallow tests, 56% 
reported not having been taught how to do it. Of those who reported having been taught, 50% either agreed or 
strongly agreed that the method used was standardized. 
 
53  
3.2.5 Availability of recommended diagnostic 
investigations according to the level of care 
 
 
• Laboratory investigations and bedside tests: blood 
glucose, Full blood count (FBC), urea and 
electrolytes, creatinine, erythrocyte sedimentation 






• Level 1 (district): no additional diagnostic tests 









• Level 3 (tertiary): CT scan, Magnetic Resonance 
Imaging (MRI) scan, Angiography, ECG, chest x- 
ray, echocardiogram (transthoracic and trans- 





• Of the recommended laboratory investigations and bedside tests; 
a) All the EU doctors reported always conducting urea and electrolytes, FBC and creatinine tests 
b) 7 out of 8 of these doctors reported that they also conducted random blood glucose and oxygen saturation 
tests on the stroke patients. One out of the 8 doctors reported conducting random blood glucose tests only when 
there was an indication; 




• All level 1 hospitals had access to chest x-rays and electrocardiograms (ECGs), however, only ECGs were 
available after office hours at all centres. Chest x-rays were available after office hours at three out of the five 
level 1 hospitals 
• Among the level 1 hospitals, CT scans were available at one hospital, echocardiograms at 2 hospitals and 
Carotid Doppler sonography at 2 hospitals but none of these investigations were available after office hours. 
 
• During the day, patients attending the level 2 hospital had access to all the investigations recommended by the 
guideline. However, only chest x-rays and ECGs were available after office hours. 
 
 
• The level 3 hospitals met all the recommended diagnostic investigations were accessible 24 hours a day 
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3.2.6  Observations  (including  frequency)  conducted 
by nurses 
• All the nurses reported that they conducted the following observations: body temperature, blood pressure, pulse 
rate and respiratory rate 
• For the remaining observations; random blood sugar tests, oxygen saturation, level of consciousness and fluid 
input and output, most of the nurses reported not routinely conducting these unless indicated by the doctor or 
there was a specific medical indication 
• In the SUs, the nurses reported that the frequency of observations ranged from ½-4 hourly and up to 6-8 hourly 
in the first 24 hours. For those in the GMWs, the frequency of observations ranged from 2-8 hourly 
• After 72 hours, most of the nurses reported that the frequency of observations depended on the condition of the 
patient at that time, existing co-morbidities, and the doctor’s orders. The frequency could increase, decrease or 
remain the same. 
3.3 The use of rt-PA in acute ischaemic strokes • rt-PA was only available at the level 3 hospitals 
• Common reasons stated by the doctors at level 1 and 2 hospitals as to why they did not administer rt-PA was 
that they has limited access to CT scans and patients presenting outside the window for thrombolysis 
• Some of the doctors from the level 3 hospitals reported that only a small fraction of acute ischaemic stroke 
patients received rt-PA, most arrived outside the window for thrombolysis. Of the 96 discharge summaries 
reviewed at GSH, only 1 patient was recorded as having received rt-PA 
• Of all the doctors from level 1 and 2 hospitals, 83% reported being able to transfer stroke patients to level 3 
hospitals if they were suitable candidates for rt-PA but also reported that this was dependent on the level 3 
hospital agreeing to take over management of the patient and also on how quickly the ambulance service could 
despatch a vehicle 
• Out of the 18 doctors, 33% set the cut off point for the administration of rt-PA at 4.5 hours, 44% set it at 1 to 4.5 
hours, 17% at 3 to 6 hours and 6% at less than 12 hours, after onset of stroke 
3.4 The presence a stroke unit • There were 2 SUs located at the two level 3 hospitals, each with only 6 beds, most of patients were admitted into 
GMWs 
• Those at level 1 and 2 hospitals were admitted into GMWs or mixed medical and surgical wards 




3.5 The presence of a MDT that conducts combined 
rounds 
• a comprehensive MDT at level 2 and 3 hospitals 
• Level 1 hospital, the minimum staff requirements; 
doctors, nurses and physiotherapists trained in 
stroke care 
• GMW doctors and nurses at three level 1 hospitals and in both SUs (level 3 hospitals) reported that MDT 
meetings were held once (level 1) and twice (SUs) a week in their wards. 
• The GMW doctors and nurses at level 2 and 3 hospitals reported that consultant ward rounds were regularly 
conducted and health professionals from other disciplines such as physiotherapy or social work were often 
consulted however no comprehensive MDT meetings were held 
• There are discrepancies in 3 lower level hospitals where the nurses agreed that MDT meetings were held in the 
wards and the doctors disagreed. 
• The MDTs in three of the level 1 hospitals and the 2 SUs included medical doctors, nurses, physiotherapists, 
social workers and dieticians. Occupational therapists always attended MDT meetings in 4 (two level 1 hospitals 
and 2 SUs) out of the 5 hospitals. Speech and language therapists were available at 4 (two level 1 hospitals and 2 
SUs) out of the 5 hospitals and attended the meetings. Psychologists were not reported to be part of any of the 
MDTs in the 5 hospitals; however, were consulted if needed. 
• Unique members of the MDT reported at one level 1 hospital were home based carers who attended each 
meeting. 
3.6 Involvement of patients and relatives • All the doctors and nurses in the SUs and GMWs at all levels either agreed or strongly agreed that patients and 
their relatives were involved in management and discharge plans 
• Issues that were reported to be discussed include stroke definition, risk factors and planned management in 
hospital and on discharge, medication for secondary prevention, feeding, rehabilitation exercises, patient 
mobilization, home safety, lifestyle modification and placement after discharge. 
• Out of the 20 medical doctors and nurses working in the GMWs and SUs, 6 reported specifically addressing 
psychological problems during discussions with patients and relatives 
• Out of the 10 nurses, only 2 reported having a standardized list of topics to discuss with patients and their 
relatives 
3.7 Secondary prevention: use of aspirin and drugs for 
hyperlipidaemia, hypertension and diabetes mellitus 
• Hypertension was the most common risk factor among ischaemic stroke patients admitted at GSH (n=96), 
followed by diabetes mellitus then hyperlipidaemia; 72%, 30% and 12%, respectively 
• Of those with hypertension and those with diabetes mellitus, 93% and 76%, respectively, received prescriptions 
for antihypertensive and anti-diabetic drugs, respectively, on discharge 
• Of those with hyperlipidaemia, 91% received prescriptions for lipid lowering medication on discharge and of 
those without a diagnosis of hyperlipidaemia, 87% received prescriptions medication 
• Of the 96 ischaemic stroke patients, 80% had prescriptions for Aspirin on discharge 
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In the two SUs, the doctors and nurses had access to protocols, diagnostic investigations, 
rt- PA and had comprehensive MDT meetings. Patients who arrived within the 
window for thrombolytic therapy frequently had an interpreted CT scan within 30 
minutes of arrival. However, the SUs only had 6 beds each, therefore, a large 
proportion of patients were admitted into GMWs at level 3 hospitals and into GMWs 
or mixed medical and surgical wards at level  1 and 2 hospitals. Most level 1  and 2  
hospitals experienced difficulties transferring patients  to higher levels  of care and  did 
not have  protocols  to  guide  their management, continued medical training programs in 
stroke care or access to some diagnostic investigations. Of all the health professionals, 
32% of the health professionals reported having written stroke management protocols 
available in the wards and EU and none of the EU doctors reported having protocols for 
referral and transfer of patients to higher level centres. Even though most did not have 
set guideline for the discussions they held with patients and their relatives, their 
involvement in their care and discharge plans was consistently reported across all levels 
of care. 
All the health professionals were asked about the challenges they faced in managing stroke 
patients at their hospitals and interventions that could be implemented to alleviate these 






























Table 3: Challenges and interventions suggested by the health professionals at the level 1, 2 and 3 hospitals 
 
Challenges Proposed interventions 
• Patient delay – most patients presented to the hospital outside the window for 
reperfusion therapy 
• Some primary health care providers failed to quickly recognize the signs and 
symptoms of stroke resulting in either delayed or no referral to higher levels of 
care 








• Delays in the time interval from being triaged to seeing the doctor (EU) 
• Community education programs: stroke risk factors, symptoms and the benefits of 
early interventions 
• Stroke education for all health professionals at all levels of care 
• Make protocols more available so that stroke patient care is standardized 
 
• Upgrading the ambulance services by either increasing the number of vehicles or 
having a fast, dedicated stroke ambulance unit that is in constant contact with the 
stroke doctors at level 3 hospitals 
• Develop acute stroke protocols for the ambulance service so that all stroke patients 
within the window for rt-PA are taken directly to level 3 hospitals or at least 
hospitals with CT scan facilities 
• Use of the flying squad for acute stroke patients 
 
• Better triage training for the nurses in the EU 
• Adopt a triage system similar to that of one level 1 hospital where an EU doctors 
sign off on each triaged patient, any acute stroke patients who had not arrived by 
ambulance were quickly identified 
• Have the ambulance service inform the stroke doctors about a patient before arrival, 
so that they bypass the general triage process and see the doctors as soon as they 
arrive 
• Shortage of nurses at all hospital levels: difficult for one nurse to do the 2 hourly 
turns on overweight patients, not enough time was spent feeding or bathing the 
patients 
• Shortage of EU doctors, physiotherapists, speech and language therapists, 
occupational therapists, dieticians and social workers at level 1 and 2 hospitals. 
• Increase the number of health professionals at all hospital levels 
• Establish more comprehensive rehabilitation departments, for example, in hospital 
speech and language therapy unit at the level 1 and 2 hospitals 
• Have the physiotherapists train the nurses how to safely move patients without 
injuring themselves or the patients 
• Employ home based carers trained in stroke care to help the nurses with the stroke 











• No designated areas in the hospital for stroke patient management • Establish acute SUs or have designated areas in the hospitals with dedicated staff 
that conduct regular stroke rounds 
• SU doctors be more involved in the care of patients in the GMWs at level 3 hospitals 
• Shortage of beds in the wards and in the EU; some stroke patients spent more 
than 24 in the EU before a bed becomes available in the wards 
• Shortage of beds at the rehabilitation facilities; stroke patients wait long periods 
for placement 
• Increase the number of beds in the SUs 
• Intensive  early  intervention  could  potentially  result  in  better  patient  outcomes 
lessening the demand on rehabilitation facility beds 
• Shortage of equipment such as pressure mattresses, wheelchairs and bathing 
equipment 
• Limited access to diagnostic investigations 
• Increase the availability of equipment 
 
• Increase access to diagnostic investigations 
• Patients who are in denial and become aggressive to nurses 
• Relatives who cannot cope with the patient at home 
• Ongoing counselling patients and relatives 
• Support for patients and relatives at home through the help of home based carers 
• Better out-patient care; provision of wheelchairs and having follow up dates that are 




Delays were a common challenge faced by the health professionals throughout all levels of 
care especially delays in patient presentation and transfer. Other challenges included limited 
access to diagnostic investigations and shortage of staff and beds. Shortage of beds resulted 
in patients staying longer in hospital, not receiving the rehabilitation services required at that 




Generally the two SUs adhered most closely to the recommended South African national 
guideline (17). However, only a minority of patients reach care in the SUs and the majority of 
patients are admitted into GMWs at all levels where there were variations in the degree to 
which the national guideline was followed. This was consistent with other studies that found 
that the quality of care offered to stroke patients in LMIC was not homogenous (2). 
Apart from the SUs, regular, comprehensive MDT meetings were held at three level 1 
hospitals. Among the health professionals only 68% reported having protocols for stroke 
management, none had protocols for upward referral and 80% of the nurses did not have a 
standardized list of topics to discuss with patients and relatives. Protocols, regular MDT 
meetings and having designated areas for stroke patients in the GMWs at all levels could help 
to standardize and also improve care. 
The guideline recommends continued training in stroke care and among the health 
professionals; nurses seem to have fewer learning opportunities. Inadequate stroke education 
among health professionals was listed as a challenge in this study, similar to other LMIC 
studies (19). Out of the 10 nurses, only four reported having received training in stroke 
management, of which three worked in level 3 hospitals. Nurses spend the most time with 
stroke patients compared to other disciplines making it essential to have educational 
programs specifically for nurses. For the smaller hospitals with fewer doctors, having 
combined seminars where all medical conditions are discussed is more efficient but stroke 
management is discussed less often. In these hospitals, it would be beneficial for both the 
patients and health professionals responsible for care to have more frequent consultant ward 
rounds where stroke management can be discussed more often. 
 
The patient delay and long ambulance waiting times are challenges that could explain why a 
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large proportion of acute stroke patients miss the window for rt-PA. Patient delay is a 
challenge some health professionals in both high and LMIC encounter in managing stroke 
patients (4, 19, 20). Other challenges faced were similar to those found in other LMIC; shortage 
of staff and equipment, lack of protocols, limited access to CT scans and inadequate 
knowledge among the health professionals (19). 
 
The demand for rehabilitation facilities is higher than what is available which results in 
patients staying longer in hospitals and blocking beds for new stroke patients. Community 
rehabilitation centres and home based carers could help with this (21). There seems to be a 
disruption of care between hospital care and community based services; home based carers 
trained in stroke care could help to provide a continuum of care that would make for an easier 
transition from the hospital to a rehabilitation facility or back to the community. One level 
1hospital in the study involved home based carers in the in-patient management of stroke 
patients who would then follow them up in the community. 
 
Similar to previous studies (22), the analysis of patient discharge summaries (n=96) found 
hypertension to be a common risk factor (72%) for stroke. Of the three co-morbidities included 
in the analysis, a large proportion of patients received prescriptions for medication and this is 
important for secondary prevention. A large proportion of the patients with and without a 
diagnosis of hyperlipidaemia were prescribed lipid lowering drug which was in line with the 
national guideline (17). 
 
This study found that the service offered to ischaemic stroke patients especially in the lower 
level hospitals was inadequate. The inadequacies highlighted in this study can be used as 
reference point moving forward; how much the health systems need to improve to reach the 
ideals set in the national guideline.  
5.0 Limitations of the study 
 
Patient discharge summaries from one centre (GSH) were reviewed and as these were 
summaries, some information may have been omitted. It would have been ideal to have 
reviewed more comprehensive medical records from all the hospitals in the CMHD. Every 
effort was made to collect data from different health professionals within each hospital but 
there may nevertheless have been some reporting bias from participants.  
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Randomly selecting a participant from all the eligible nurses at a particular hospital was 
difficult because they work in shifts and it would not be possible to conduct interviews at 
night. Therefore, not all the eligible nurses at a hospital were sampled; participants were 
randomly selected from the eligible nurses working the day shift on the day of the interview. 
The data was collected and analysed by one researcher however to improve accuracy and 
increase transparency, the data analysis records and  interview audio files and transcripts were 
made available to the supervisors.  
6.0 Conclusion 
 
The two SUs at the level 3 hospitals adhered most closely to the recommended South African 
national guideline. Variations in the level adherence existed in the GMWs in level 1, 2 and 3 
hospitals. Factors such as a shortage of staff, limited access to diagnostic investigations and 
patient delay, influenced the level of adherence to the guideline. Interventions should be put 
in place to alleviate some of these challenges if the quality of stroke care as recommended by 
the national guideline, is to improve. 
 
The SUs could organise stroke courses for the hospitals in their catchment areas to educate 
health professionals on stroke care. Having seminars such as these could help create a 
coordinated and standardized system for stroke care. Guidelines for topics to discuss would 
ensure that all patients and their relatives have all the information they need. Pamphlets on 
stroke care printed in different languages can be distributed to educate the patients and 
relatives. 
In addition to describing the quality of current ischaemic stroke care practices in the CMHD, 
the study also highlighted the challenges that the health professionals faced in managing stroke 
patients. The study, however, did not examine the background of these challenges, that is, why 
there were shortages of beds, equipment or staff. Recommendations f or further research 
include an analysis of the health systems in the CMHD to understand why the service delivery 
for stroke patients in the lower level hospitals is adequate, after which intervention programs 
can be implemented. Monitoring systems can also be developed to continue evaluating the 
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1.1 Participant information form 
 
Title of research project: Quality of current ischaemic stroke practices in the Cape 
metro health district, South Africa 
Introduction 
 
My name is Vimbai Mandizvidza and I am a Masters student at the University of Cape Town 
School Of Public Health and Family Medicine. I am conducting a study to determine the 
quality of current ischaemic stroke care practices in a select number of level 1, 2 and 3 
hospitals in the Cape Metro Health District. The study has been approved by the Human 
Subjects Research Ethics Committee in the Health Sciences Faculty at the University of Cape 
Town. 
There is more information about the study below and if you have any questions as you go 
though the information, please ask and I will explain. After you have read the information, 
have asked any questions you might have and understood all the information provided, you 
will be invited to take part in the study. If you agree to take part in the study, you will then be 
asked to sign a consent form. 
1. What is the purpose of the study? 
 
The purpose of the study is to determine the quality of current ischaemic stroke care 
practices in level 1, 2 and 3 hospitals in the Cape Metro Health  District.  Data 
collected from this study will be used to develop interventions that will bridge the gap 
between current stroke care practices and the South African stroke guideline 
recommendations. These interventions can possibly result in better stroke patient 





2. Why have I been chosen to participate in this study? 
 
Doctors and nurses involved in the management of stroke patients in the emergency 
unit and in the ward have been randomly selected to participate in this study. The 
criterion for inclusion is that the doctor or nurse needs to have worked in their 
respective departments for at least 6 months in this hospital. You have been selected 
because you meet this criterion for inclusion in the study. 
 
 
3. What will happen if I agree to participate in the study? 
 
I will ask you a number of questions in an interview. The questions will involve your 
work in the management of stroke patients at this hospital. The interview will be 
recorded to ensure accurate collection of information and I will also take some notes. I 
will interview you in a private room at a time that is convenient for you. The 
interview will last about 30 to 45 minutes. 
 
 
4. Do I have to participate in the study? 
 
No. Please note that it is your decision whether or not to participate in the study. If 
you decide not to participate in the study, you will not incur any penalties. If you 
decide to participate in the study, you are still free to withdraw at any time and you 





The consent form and all the information collected during the interview will be kept 
strictly confidential. When the report is drawn up, I will make every effort to ensure 
anonymity of the responses so that the person who made comments or suggestions 
cannot be identified from the report. In the report, your responses will be anonymized; 
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All the questionnaires, recordings and consent forms will  be stored in a locked 
cupboard at the University Of Cape Town School Of Public Health and Family 
Medicine and any data stored in computer files will be password protected. 
 
 
7. How will participating in the study benefit me? 
 
There will be no direct benefit to you. The possible benefit is to generate information to 
improve the management of ischaemic strokes. After all the interviews for your health 
facility have been completed, you will be provided with information on the current 
South African ischaemic stroke guidelines. There will be no financial compensation. 
8. What will happen to the information you collect during the interview? 
 
 
The information collected during this study and the results obtained will be published in 
the form of a Masters dissertation. This dissertation will be available at the University of 
Cape Town medical school library and it can also be accessed online. The results of 
this study may also be published in a scientific journal. In all the publications, your 
identity will be protected and I will not use any names or mention any factors that might 
identify you in the report. 
9. If I need more information, whom do I contact? 
 
 
If you have any other questions that have not been answered above or you need 
further clarification on certain points, you can contact; 
i. Dr. Vimbai Mandizvidza, University of Cape Town School of Public Health. 
+27606916171. drvimbai@gmail.com. 
ii. Principal Investigator: Professor Leslie London, University of Cape Town 
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School of Public Health. Tel (021) 406 6524 
iii. Ms Shuretta Thomas, Health Sciences Human Research Ethics Committee, 

































2. Consent form 
 
Title of research project: Quality of current ischaemic stroke practices in the Cape 
metro health district, South Africa 
1. I  have  read  the  information  form  and  have  been  given  the  opportunity  to  ask 
questions. Any questions I had were answered. 
2. I understand that my participation in this study is voluntary and that I can withdraw 
from the study at any time. 
3. I understand that my comments may be included in the final report but will be done 
in a way that I cannot be personally identified. 
4. I understand that this research will be published in the form of a Masters dissertation 
and may also be published in research journal. 
5. I agree to participate in this study. 
 
6. I agree to have notes taken during the interview. 
 




Printed name (participant): …………………………………………………………………. 
Signature (participant): …………………………………………………………………….. 
Printed name (witness): …………………………………………………………………….  
Signature (witness): ………………………………………………………………………… 
Date: …………………………………………………………………………………........... 








3.1 Nurse in the ward 
1. What is your rank as a nurse in this hospital?




2. i. How long have you been working as a nurse?
Years Months 
ii. And how long have you been managing stroke patients as a nurse on the ward at
this hospital?  [To be excluded if less than 6 months] 
Years Months 
3. i.  Besides  your  nursing  training,  have  you  received  any  special  training  in
the management of stroke patients?
Yes No 
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4. i. Do you have seminars or tutorials that focus on the management of stroke patients 










5. i. Does your ward have written protocols on the management of stroke patients? 
Yes No 
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iii. Are these protocols accessible to all health professionals who want to use them? 
[Please indicate your degree of agreement or disagreement with the statement using 
the scale below in your response] 















iii. Do you have a designated area in the hospital where hospital beds are reserved 
specifically for the management of stroke patients? 
Yes No 
73  
iv. If no, in which ward/s are stroke patients admitted in this hospital? [Note if 
respondent gives more than one response] 
General medical ward 




7.   i. When a patient is admitted onto the ward with a diagnosis of stroke, how often do 






ii. Which of the following observations do you conduct on the stroke patients? [Tick 
all that apply] 








Other: Blood sugar 
 
Fluid input and output 
74  
iii. Does the frequency of observations change after patients have been admitted in 
the ward for more than 72 hours? [Please indicate your degree of agreement or 
disagreement with the statement using the scale below in your response] 
1 Strongly disagree     2 Disagree       3 Undecided   4 Agree 5 Strongly agree 
 






8. i. Is a swallow test routinely done on acute stroke patients before they are allowed 
to eat or drink? [Please indicate your degree of agreement or disagreement with the 
statement using the scale below in your response] 
1 Strongly disagree     2 Disagree       3 Undecided   4 Agree 5 Strongly agree 
 







iii. If you have to do it, have you been taught how to do a swallow test? 
Yes No 
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iv. Is everyone who needs to know how to conduct a swallow test, taught to perform it 
in exactly the same way? [Please indicate your degree of agreement or 
disagreement with the statement using the scale below in your response] 













9. i. Are meetings held by the health professionals responsible for stroke patient care 




























iv. Does the doctor in charge of stroke patient care attend each meeting? [Please 
indicate your degree of agreement or disagreement with the statement using the 
scale below in your response] 
1 Strongly disagree     2 Disagree       3 Undecided   4 Agree 5 Strongly agree 
 
10. i. Are the patients and their relatives currently involved in the patient’s discharge 
plans? [Please indicate your degree of agreement or disagreement with the 
statement using the scale below in your response] 
1 Strongly disagree     2 Disagree       3 Undecided   4 Agree 5 Strongly agree 
 







iii. What issues are discussed during these meetings? [Tick all that apply] 
 
Patient and relative education: 
 

















iv. Do you have standardised guidelines with a list of topics that are discussed with 


















12. In your opinion, what interventions can be put in place to improve the care of stroke 




3.2 Doctor in the ward 
 

















ii.  How  long  have  you  been  managing  stroke  patients  in  this  hospital?  [To  be 























4. i. Do you have any scheduled seminars or tutorials on the management of stroke 

































iii. Are these protocols currently accessible to all health professionals who want to use 
them? [Please indicate your degree of agreement or disagreement with the statement 
using the scale below in your response] 













iii. Do  you  have  a  designated  area  in  the  hospital  where  hospital  beds  are  reserved 





iv. If no, in which ward or wards are stroke patients admitted in this hospital? [Note if 
respondent gives more than one response] 
General medical ward 












ii. Do you currently score each stroke patient admitted using NIHSS? [Please indicate your 
degree of agreement or disagreement with the statement using the scale below in your 
response] 
1 Strongly disagree 2 Disagree       3 Undecided   4 Agree 5 Strongly agree 
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8. i. Up to how many hours after the onset of an acute ischaemic stroke can a patient 


























9. i. Do you have the following diagnostic tests at this hospital? 
 
CT scan yes  no 
 
MRI scan yes  no 
 
Chest x-ray yes  no 
 
Electrocardiogram yes  no 
 
Echocardiogram yes  no 
 





ii. Among the diagnostic tests that you have available, which are available 24 hours a 
day? 


















10. i. Are meetings held by the health professionals responsible for stroke patient care to 












iii. Do  the  ward  doctors  attend  these  meetings?  [Please  indicate  your  degree  of 
agreement or disagreement with the statement using the scale below in your response] 
1 Strongly disagree 2 Disagree 3 Undecided 4 Agree 5 Strongly agree 











11. i. Are the patients and their relatives currently involved in the patients’ discharge plans?
[Please indicate your degree of agreement or disagreement with the statement using the 
scale below in your response] 
1 Strongly disagree 2 Disagree 3 Undecided 4 Agree 5 Strongly agree 
ii. If you agree, how are they involved?
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iii. What issues are discussed during these meetings? [Tick all that apply]
Patient and relative education: 








12. What  are  the  difficulties  you  have  encountered  in  the  management  of  stroke
patients in your hospital? 
13. In your opinion, what interventions can be put in place to improve the care of stroke
patients in this hospital? 
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3.3 Emergency unit doctor 




2. i. How long have you been working as a medical doctor?
Years Months 
ii. How long have you been working in the emergency unit at this hospital? [To be
excluded if less than 6 months] 
Years Months 
3. i. Since qualifying, have you received any training in the management of patients
with acute stroke in the emergency unit?
Yes No
ii. If yes, how long ago did you receive this training?
Years Months 
90 
iii. Describe the kind of training you received.
4. Are strokes currently treated as an emergency in the emergency unit of this
hospital? [Please indicate your degree of agreement or disagreement with the
statement using the scale below in your response]
1 Strongly disagree 2 Disagree 3 Undecided 4 Agree 5 Strongly agree
5. i. Does the emergency unit have written protocols on the management of stroke
patients? 
Yes No 
ii. If yes, where are they placed?
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iii. Are these protocols currently accessible to all health professionals who want to use
them? [Please indicate your degree of agreement or disagreement with the statement 
using the scale below in your response] 
1 Strongly disagree 2 Disagree 3 Undecided 4 Agree 5 Strongly agree 
6. i. Are you familiar with the term stroke unit?
Yes No 
ii. If yes, what is a stroke unit?
iii. Do you have a designated area in the hospital where hospital beds are reserved
specifically for the management of stroke patients? 
Yes No 
iv. If no, in which ward/s are stroke patients admitted in this hospital? [Note if
respondent gives more than one response] 
General medical ward 
Intensive care unit 
Other, specify 
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7. i. Are you familiar with the National Institutes of Health Stroke Scale (NIHSS)?
Yes No 
ii. Do you currently score each stroke patient treated in the emergency unit using
NIHSS? [Please indicate your degree of agreement or disagreement with the statement 
using the scale below in your response] 
1 Strongly disagree 2 Disagree 3 Undecided 4 Agree 5 Strongly agree 
8. Are the following investigations conducted on a patient with a suspected stroke?
Blood glucose (rapid test using dextrostix) yes no 
Full blood count yes no 
Urea, creatinine and electrolytes yes no 
Erythrocyte sedimentation rate (ESR) yes no 
C- reactive protein (CRP) yes no 
Oxygen saturation yes no 
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9. i. In your hospital, is a swallow test routinely performed on acute stroke patients before
they are allowed to eat or drink? [Please indicate your degree of agreement or disagreement 
with the statement using the scale below in your response] 
1 Strongly disagree 2 Disagree 3 Undecided 4 Agree 5 Strongly agree 
ii. Who does the swallow test in the emergency unit of this hospital?
iii. If you have to do it, have you been taught how to do the swallow test?
Yes No 
iv. How is a swallow test performed at this hospital?
v. Is the method used to perform a swallow test at this hospital standardized? [Please
indicate your degree of agreement or disagreement with the statement using the scale 
below in your response] 
1 Strongly disagree 2 Disagree 3 Undecided 4 Agree 5 Strongly agree 
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10. i. Up to how many hours after the onset of an acute ischaemic stroke can a patient
receive intravenous thrombolytics? 
Hours 
ii. Can an acute ischaemic stroke patient receive intravenous thrombolytics at this
hospital? 
Yes No 
iii. If no, why?
iv. Are  you  able  to  transfer  patients  to  tertiary  hospitals  if  they  are  suitable
candidates for thrombolysis? 
Yes No 
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11. i. Do you have the following diagnostic tests at this hospital? 
 





yes                                      no 
  Chest x-ray 
 
yes                                      no 
 
Electrocardiogram yes                                      no 
 






















iii. Do you have health professionals available to interpret the CT scans? 
Yes No 
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iv. If yes, are they available to interpret the scans after working
hours? Yes No
12. What is the average estimated time period (minutes or hours), in your opinion,
between the arrival of the suspected acute stroke patient in the emergency unit and 
obtaining an interpreted CT or MRI scan? 
Hours Minutes 
13. Describe the difficulties you have encountered in the management of stroke patients
in this hospital. 
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14. In your opinion, what interventions can be put in place to improve the care of stroke 




























4.0 Audit of stroke care services as per South African guidelines for the 
management of ischaemic stroke and transient ischaemic attack 2010 
4.1 Level 1 hospitals (district) 
Name of hospital ………………………………………………………………………….. 





2.1. Acute and post-acute management of stroke – with attention to active
management of physiological abnormalities and to maintain homeostasis 
2.2. Referral and transfer of select patient to level 2 or 3 hospital 
3. Education of the patient and their relatives - standardised guidelines with a list of
topics that are discussed with the patients and their relatives
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4.2 Level 2 hospitals (regional) 
Name of hospital ………………………………………………………………………….. 
1. Designated area in the hospital with designated stroke unit beds
2. A multidisciplinary team which includes;
2.1. Medical doctors including a stroke physician and an internal medicine
specialist cover trained in stroke care 
2.2. Nurse 
2.3. Physiotherapist 
2.4. Occupational therapist 
2.5. Speech and language therapist 
2.6. Social worker 
2.7. Dietician 
2.8. Psychologist 
3. Education of the patient and their relatives - standardised guidelines with a list of
topics that are discussed with the patients and their relatives 
4. Protocols for;
4.1. Acute and post-acute management of stroke – with attention to active
management of physiological abnormalities and to maintain homeostasis 
4.2. Intravenous thrombolysis for acute ischaemic stroke 
4.3. Transfer of select stroke patients to level 3 hospitals 
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5. Investigations available (radiological and laboratory);
5.1. Computerized tomography scan (CT scan)
5.2. Electrocardiogram (ECG) 
5.3. Chest x-ray (CXR) 
5.4. Full blood count (FBC) 
5.5. Erythrocyte sedimentation rate (ESR) 
5.6. International normalized ratio (INR) 
5.7. Syphilis testing (VDRL and RPR) 
5.8. Blood sugar 
5.9. Urea and electrolytes 
6. Access to an echocardiogram
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4.3 Level 3 hospitals (tertiary) 
Name of hospital ………………………………………………………………………….. 
1. Designated area in the hospital with designated stroke unit beds
2. A multidisciplinary team which includes;
2.1. Medical doctors including stroke specialists (specialist physicians or
neurologists trained in stroke care and/ or neurosurgical service) 
2.2. Nurses 
2.3. Physiotherapists 
2.4. Occupational therapists 
2.5. Speech and language therapists 
2.6. Social workers 
2.7. Dieticians 
2.8. Psychologists 
3. Education of the patient and their relatives - standardised guidelines with a list of
topics that are discussed with the patients and their relatives 
4. Protocols for;
4.1. Acute and post-acute management of stroke – with attention to active
management of physiological abnormalities and to maintain homeostasis 
4.2. Intravenous and intra-arterial interventional (thrombolysis) management of 
acute ischaemic stroke 
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4.3. Investigation and management of stroke in young patient 
5. Investigations available (radiological and laboratory);
5.1. Computerized tomography scan (CT scan)
5.2. Magnetic resonance imaging (MRI) 
5.3. Angiography 
5.4. Duplex Doppler carotid sonography 
5.5. Echocardiograms (including transthoracic and trans-oesophageal echocardiogram) 
5.6. Electrocardiogram (ECG) 
5.7. Chest x-ray (CXR) 
5.8. Full blood count (FBC) 
5.9. Erythrocyte sedimentation rate (ESR) 
5.10. International normalized ratio (INR) 
5.11. Syphilis testing (VDRL and RPR) 
5.12. Blood sugar 
5.13. Urea and electrolytes 
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5.0 Patient discharge summaries 
Patient ID 0000 
Date of birth DD/MMM/YYYY Age years 
Gender: Male □ Female□
Duration of admission……………………………………………………………. 
Admitting ward: Acute Stroke Unit □ 
Medical Ward □ 
Co-morbidities: Hypertension □ 
Diabetes Mellitus □ 
Hyperlipidaemia □ 
Other………………………………………………………… 
Lab Investigations: FBC □ U+E □ Creatinine □ 


















Medication for secondary prevention: 
Aspirin □ 
Medication for Hypertension □ 
…………………………………..………………………………….. 
…………………………………..………………………………….. 
Medication for Diabetes Mellitus □
……………………………………………………………………… 
…………………………………..………………………………….. 










5.1. Description of variables and coding for the patient discharge summaries 
Variable name Description Coding 
Age Numerical variable measured in 
years 
Gender Categorical variable Male = 1 
Female = 0 
Duration of admission Numerical variable measured in 
days 
Admitting ward Categorical variable. The ward in 
which the ischaemic stroke patient 
was admitted. 
Acute stroke unit = 1 
General medical ward = 0 
Co-morbidities Categorical variable. Whether the 
patient was hypertensive, diabetic 
or had hyperlipidaemia 
Hypertension: Yes =1, 
No = 0 
Diabetes mellitus: Yes =1, 
No = 0 
Hyperlipidaemia: Yes =1, 
No = 0 
Lab investigations Categorical variable. Mandatory FBC: Yes =1, No = 
laboratory investigations that 0 
should be performed on every U + E: Yes =1, No = 
ischaemic stroke patient 0 
Creatinine: Yes =1, No = 0 
RBS: Yes =1, No = 
0 
ESR: Yes =1, No = 
0 
CRP: Yes =1, No = 
0 
Other investigations Categorical variable. Other 
mandatory investigations that 
should be performed on every 
ischaemic stroke patient 
ECG Yes =1, No = 0 
CXR Yes =1, No = 0 
The use of rt-PA Categorical variable. Whether rt-PA 
was given to an ischaemic stroke 
patient or not 
Yes = 1 
No = 0 
Medication for 
secondary prevention 
Categorical variable. Medications 
that were given to the patient for 
secondary prevention of ischaemic 
stroke. 
Aspirin Yes =1, No = 0 
Anti-hypertensive drugs 
Yes =1, No = 0 
Drugs for Diabetes Mellitus: 
Yes =1, 
No = 0 
Drugs for hyperlipidaemia: 
Yes =1, No = 0 
Discharge Categorical variable. Where the 
patient was discharged to after acute 
and post-acute ischaemic stroke  
care was given to the patient. 
Home = 1 
Institution = 0 
106 
6.0  Letter of approval from UCT Human Research Ethics Committee  
signature removed
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7.0  Instructions for authors: South African Medical Journal 
Manuscript preparation 
General article format/layout 
Accepted manuscripts that are not in the correct format specified in these guidelines will be returned to the 
author(s) for correction, which will delay publication. 
General: 
• Manuscripts must be written in UK English. 
• The manuscript must be in Microsoft Word format. Text must be single-spaced, in 12-point Times New Roman
font, and contain no unnecessary formatting (such as text in boxes).
• Please make your article concise, even if it is below the word limit. 
• Qualifications, full affiliation (department, school/faculty, institution, city, country) and contact details
of ALL authors must be provided in the manuscript and in the online submission process.
• Abbreviations should be spelt out when first used and thereafter used consistently, e.g. 'intravenous
(IV)' or 'Department of Health (DoH)'.
• Include sections on Acknowledgements, Conflict of Interest, Author Contributions and Funding
sources. If none is applicable, please state ‘none’.
• Scientific measurements must be expressed in SI units except: blood pressure (mmHg) and haemoglobin
(g/dL).
• Litres is denoted with an uppercase L e.g. 'mL' for millilitres). 
• Units should be preceded by a space (except for % and ºC), e.g. '40 kg' and '20 cm' but '50%' and '19ºC'. 
• Please be sure to insert proper symbols e.g. µ not u for micro, a not a for alpha, b not B for beta, etc. 
• Numbers should be written as grouped per thousand-units, i.e. 4 000, 22 160. 
• Quotes should be placed in single quotation marks: i.e. The respondent stated: '...' 
• Round brackets (parentheses) should be used, as opposed to square brackets, which are reserved for
denoting concentrations or insertions in direct quotes.
• If you wish material to be in a box, simply indicate this in the text. You may use the table format –this is
the only exception. Please DO NOT use fill, format lines and so on.
SAMJ is a generalist medical journal, therefore for articles covering genetics, it is the responsibility 
of authors to apply the following: 
- Please ensure that all genes are in italics, and proteins/enzymes/hormones are not.
- Ensure that all genes are presented in the correct case e.g. TP53 not Tp53.
**NB: Copyeditors cannot be expected to pick up and correct errors wrt the above, although they will raise
queries where concerned.
- Define all genes, proteins and related shorthand terms at first mention, e.g. ‘188del11’ can be glossed as ‘an
11 bp deletion at nucleotide 188.’
- Use the latest approved gene or protein symbol as appropriate:
• Human Gene Mapping Workshop (HGMW): genetic notations and symbols 
• HUGO Gene Nomenclature Committee: approved gene symbols and nomenclature 
• OMIM: Online Mendelian Inheritance in Man (Gdalevich et al.) nomenclature and instructions 
• Bennet et al. Standardized human pedigree nomenclature: Update and assessment of the recommendations
of the National Society of Genetic Counselors. J Genet Counsel 2008;17:424-433: standard human
pedigree nomenclature.
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Preparation notes by article type 
• Research
 d to a s 
• 
CME •








Guideline word limit: 4 000 words 
Research articles describe the background, methods, results and conclusions of an original 
research study. The article should contain the following sections: introduction, methods, 
results, discussion and conclusion, and should include a structured abstract (see below). The 
introduction should be concise – no more than three paragraphs – on the background to the 
research question, and must include references to other relevant published studies that 
clearly lay out the rationale for conducting the study. Some common reasons for conducting 
a study are: to fill a gap in the literature, a logical extension of previous work, or to answer 
an important clinical question. If other papers related to the same study have been 
published previously, please make sure to refer to them specifically. Describe the study 
methods in as much detail as possible so that others would be able to replicate the study 
should they need to. Results should describe the study sample as well as the findings from 
the study itself, but all interpretation of findings must be kept in the discussion section, 
which should consider primary outcomes first before any secondary or tertiary findings or 
post-hoc analyses. The conclusion should briefly summarise the main message of the paper 
and provide recommendations for further study. 
Select figures and tables for your paper carefully and sparingly. Use only those figures that 
provided added value to the paper, over and above what is written in the text. 
Do not replicate data in tables and in text . 
Structured abstract 
• This should be 250-400 words, with the following recommended headings: 
o Background: why the study is being done and how it relates to other published work. o Objectives:
what the study intends to find out 
o Methods: must include study design, number of participants, description of the intervention, primary and secondary
outcomes, any specific analyses that were done on the data.
o Results: first sentence must be brief population and sample description; outline the results according to the methods
described. Primary outcomes must be described first, even if they are not the most significant findings of the study.
o Conclusion: must be supported by the data, include recommendations for further study/actions. 
• Please ensure that the structured abstract is complete, accurate and clear and has been approved by all authors. 
• Do not include any references in the abstracts.
Here is an example of a good abstract. 
109 
Main article 
All articles are to include the following main sections: Introduction/Background, Methods, Results, 
Discussion, Conclusions. 
The following are additional heading or section options that may appear within these: 
• Objectives (within Introduction/Background): a clear statement of the main aim of the study and the major
hypothesis tested or research question posed
• Design (within Methods): including factors such as prospective, randomisation, blinding, placebo control,
case control, crossover, criterion standards for diagnostic tests, etc.
• Setting (within Methods): level of care, e.g. primary, secondary, number of participating centres.
• Participants (instead of patients or subjects; within Methods): numbers entering and completing the study, sex,
age and any other biological, behavioural, social or cultural factors (e.g. smoking status, socioeconomic group,
educational attainment, co-existing disease indicators, etc)that may have an impact on the study results. Clearly
define how participants were enrolled, and describe selection and exclusion criteria.
• Interventions (within Methods): what, how, when and for how long. Typically for randomised controlled
trials, crossover trials, and before and after studies.
• Main outcome measures (within Methods): those as planned in the protocol, and those ultimately
measured. Explain differences, if any.
Results 
• Start with description of the population and sample. Include key characteristics of comparison groups.
• Main results with (for quantitative studies) 95% confidence intervals and, where appropriate, the exact level of
statistical significance and the number need to treat/harm. Whenever possible, state absolute rather than
relative risks.
• Do not replicate data in tables and in text. 
• If presenting mean and standard deviations, specify this clearly. Our house style is to present this as follows: 
• E.g.: The mean (Mosselman et al.) birth weight was 2 500 (1 210) g. Do not use the ± symbol for mean
(Mosselman et al.).
• Leave interpretation to the Discussion section. The Results section should just report the findings as per
the Methods section.
Discussion 
Please ensure that the discussion is concise and follows this overall structure – sub-headings are not needed: 
• Statement of principal findings 
• Strengths and weaknesses of the study 
• Contribution to the body of knowledge 
• Strengths and weaknesses in relation to other studies 
• The meaning of the study – e.g. what this study means to clinicians and policymakers 
• Unanswered questions and recommendations for future research
Conclusions 
This may be the only section readers look at, therefore write it carefully. Include primary conclusions and 
their implications, suggesting areas for further research if appropriate. Do not go beyond the data in the 
article. 
